-- Generated by Craft v2.6.3005 on Feb 9, 2018, 9:42:02 PM.

--
-- Disable foreign key checks and autocommit.
--

SET FOREIGN_KEY_CHECKS = 0;
SET SQL_MODE = "NO_AUTO_VALUE_ON_ZERO";
SET AUTOCOMMIT = 0;
SET NAMES utf8;


DROP TABLE IF EXISTS `craft_assetfiles`;


--
-- Schema for table `craft_assetfiles`
--
CREATE TABLE `craft_assetfiles` (
  `id` int(11) NOT NULL,
  `sourceId` int(11) DEFAULT NULL,
  `folderId` int(11) NOT NULL,
  `filename` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `kind` varchar(50) COLLATE utf8_unicode_ci NOT NULL DEFAULT 'unknown',
  `width` int(11) unsigned DEFAULT NULL,
  `height` int(11) unsigned DEFAULT NULL,
  `size` bigint(20) unsigned DEFAULT NULL,
  `dateModified` datetime DEFAULT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_assetfiles_filename_folderId_unq_idx` (`filename`,`folderId`),
  KEY `craft_assetfiles_sourceId_fk` (`sourceId`),
  KEY `craft_assetfiles_folderId_fk` (`folderId`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_assetfolders`;


--
-- Schema for table `craft_assetfolders`
--
CREATE TABLE `craft_assetfolders` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `parentId` int(11) DEFAULT NULL,
  `sourceId` int(11) DEFAULT NULL,
  `name` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `path` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_assetfolders_name_parentId_sourceId_unq_idx` (`name`,`parentId`,`sourceId`),
  KEY `craft_assetfolders_parentId_fk` (`parentId`),
  KEY `craft_assetfolders_sourceId_fk` (`sourceId`)
) ENGINE=InnoDB AUTO_INCREMENT=2 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_assetindexdata`;


--
-- Schema for table `craft_assetindexdata`
--
CREATE TABLE `craft_assetindexdata` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `sessionId` varchar(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '',
  `sourceId` int(10) NOT NULL,
  `offset` int(10) NOT NULL,
  `uri` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `size` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `recordId` int(10) DEFAULT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_assetindexdata_sessionId_sourceId_offset_unq_idx` (`sessionId`,`sourceId`,`offset`),
  KEY `craft_assetindexdata_sourceId_fk` (`sourceId`)
) ENGINE=InnoDB AUTO_INCREMENT=171 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_assetsources`;


--
-- Schema for table `craft_assetsources`
--
CREATE TABLE `craft_assetsources` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `name` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `handle` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `type` varchar(150) COLLATE utf8_unicode_ci NOT NULL,
  `settings` text COLLATE utf8_unicode_ci,
  `sortOrder` smallint(6) unsigned DEFAULT NULL,
  `fieldLayoutId` int(10) DEFAULT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_assetsources_name_unq_idx` (`name`),
  UNIQUE KEY `craft_assetsources_handle_unq_idx` (`handle`),
  KEY `craft_assetsources_fieldLayoutId_fk` (`fieldLayoutId`)
) ENGINE=InnoDB AUTO_INCREMENT=2 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_assettransformindex`;


--
-- Schema for table `craft_assettransformindex`
--
CREATE TABLE `craft_assettransformindex` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `fileId` int(11) NOT NULL,
  `filename` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `format` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `location` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `sourceId` int(11) DEFAULT NULL,
  `fileExists` tinyint(1) DEFAULT NULL,
  `inProgress` tinyint(1) DEFAULT NULL,
  `dateIndexed` datetime DEFAULT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  KEY `craft_assettransformindex_sourceId_fileId_location_idx` (`sourceId`,`fileId`,`location`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_assettransforms`;


--
-- Schema for table `craft_assettransforms`
--
CREATE TABLE `craft_assettransforms` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `name` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `handle` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `mode` enum('stretch','fit','crop') COLLATE utf8_unicode_ci NOT NULL DEFAULT 'crop',
  `position` enum('top-left','top-center','top-right','center-left','center-center','center-right','bottom-left','bottom-center','bottom-right') COLLATE utf8_unicode_ci NOT NULL DEFAULT 'center-center',
  `height` int(10) DEFAULT NULL,
  `width` int(10) DEFAULT NULL,
  `format` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `quality` int(10) DEFAULT NULL,
  `dimensionChangeTime` datetime DEFAULT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_assettransforms_name_unq_idx` (`name`),
  UNIQUE KEY `craft_assettransforms_handle_unq_idx` (`handle`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_categories`;


--
-- Schema for table `craft_categories`
--
CREATE TABLE `craft_categories` (
  `id` int(11) NOT NULL,
  `groupId` int(11) NOT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  KEY `craft_categories_groupId_fk` (`groupId`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_categorygroups`;


--
-- Schema for table `craft_categorygroups`
--
CREATE TABLE `craft_categorygroups` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `structureId` int(11) NOT NULL,
  `fieldLayoutId` int(11) DEFAULT NULL,
  `name` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `handle` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `hasUrls` tinyint(1) unsigned NOT NULL DEFAULT '1',
  `template` varchar(500) COLLATE utf8_unicode_ci DEFAULT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_categorygroups_name_unq_idx` (`name`),
  UNIQUE KEY `craft_categorygroups_handle_unq_idx` (`handle`),
  KEY `craft_categorygroups_structureId_fk` (`structureId`),
  KEY `craft_categorygroups_fieldLayoutId_fk` (`fieldLayoutId`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_categorygroups_i18n`;


--
-- Schema for table `craft_categorygroups_i18n`
--
CREATE TABLE `craft_categorygroups_i18n` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `groupId` int(11) NOT NULL,
  `locale` char(12) COLLATE utf8_unicode_ci NOT NULL,
  `urlFormat` text COLLATE utf8_unicode_ci,
  `nestedUrlFormat` text COLLATE utf8_unicode_ci,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_categorygroups_i18n_groupId_locale_unq_idx` (`groupId`,`locale`),
  KEY `craft_categorygroups_i18n_locale_fk` (`locale`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_content`;


--
-- Schema for table `craft_content`
--
CREATE TABLE `craft_content` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `elementId` int(11) NOT NULL,
  `locale` char(12) COLLATE utf8_unicode_ci NOT NULL,
  `title` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `field_body` text COLLATE utf8_unicode_ci,
  `field_veinsDates` varchar(100) COLLATE utf8_unicode_ci DEFAULT NULL,
  `field_veinsHeader` varchar(50) COLLATE utf8_unicode_ci DEFAULT NULL,
  `field_veinsSubheader` text COLLATE utf8_unicode_ci,
  `field_bodyTitle1` text COLLATE utf8_unicode_ci,
  `field_bodyText1` text COLLATE utf8_unicode_ci,
  `field_testimonialQuoteOne` text COLLATE utf8_unicode_ci,
  `field_testimonialSourceOne` text COLLATE utf8_unicode_ci,
  `field_viva2018Text` text COLLATE utf8_unicode_ci,
  `field_veinsAtVivaText` text COLLATE utf8_unicode_ci,
  `field_industry` text COLLATE utf8_unicode_ci,
  `field_virtualVivaHeader` text COLLATE utf8_unicode_ci,
  `field_virtualVivaBody` text COLLATE utf8_unicode_ci,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_content_elementId_locale_unq_idx` (`elementId`,`locale`),
  KEY `craft_content_title_idx` (`title`),
  KEY `craft_content_locale_fk` (`locale`)
) ENGINE=InnoDB AUTO_INCREMENT=93 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

--
-- Data for table `craft_content`
--

INSERT INTO `craft_content` (`id`, `elementId`, `locale`, `title`, `field_body`, `field_veinsDates`, `field_veinsHeader`, `field_veinsSubheader`, `field_bodyTitle1`, `field_bodyText1`, `field_testimonialQuoteOne`, `field_testimonialSourceOne`, `field_viva2018Text`, `field_veinsAtVivaText`, `field_industry`, `field_virtualVivaHeader`, `field_virtualVivaBody`, `dateCreated`, `dateUpdated`, `uid`) VALUES
 ('1', '1', 'en_us', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, '2018-01-24 18:37:16', '2018-02-03 17:48:05', 'bd075446-6e43-432c-a3b7-905b7c9370eb'),
 ('2', '2', 'en_us', 'Home', '<p>It’s true, this site doesn’t have a whole lot of content yet, but don’t worry. Our web developers have just installed the CMS, and they’re setting things up for the content editors this very moment. Soon Ec2-54-165-224-216.compute-1.amazonaws.com will be an oasis of fresh perspectives, sharp analyses, and astute opinions that will keep you coming back again and again.</p>', '', '', '', '', '', '', '', NULL, NULL, NULL, NULL, NULL, '2018-01-24 18:37:18', '2018-02-09 21:28:21', '7fa20ec0-c217-4356-adf3-ee6b857238f8'),
 ('90', '90', 'en_us', 'VIVA Continues Its Focus on Multidisciplinary Education', '<p>As the field of vascular medicine rapidly evolves, VIVA (Vascular InterVentional Advances) continues to be at the forefront of interactive, multispecialty education. Now in its 16th year, this annual conference offers attendees the opportunity to hear distinguished speakers in the vascular medicine field discuss the most relevant issues. VIVA’s hot topics for 2018 include complications management, critical limb ischemia, pharmacotherapy, a special session on disruptive technologies, and more.</p>\n<p>As VIVA Physicians Board President Dr. John Kaufman notes, “It’s difficult for a practitioner to sift through new information to understand what’s important. VIVA is structured to provide you with that analysis, that critical view of the data and information, in a compact way from multiple specialists.” VIVA’s faculty and attendees provide representation from interventional cardiology, interventional radiology, vascular and cardiothoracic surgery, and vascular medicine. The benefit of this is that “you won’t get just the party line from one group of individuals,” Kaufman says. “You’ll hear from everybody in a distilled manner—what’s important and what you need to know going forward.”</p>\n<p>VIVA offers vascular medicine practitioners of all levels a chance to interact with speakers and attendees through a variety of educational formats. For fellows and physicians-in-training there are presentations on finding and succeeding in a first job, the importance of achieving an optimal work-life balance, and guidance on making contributions in the field.</p>\n<p>Additionally, attendees can leverage the power of the Virtual VIVA app to interact with faculty, view live cases, and review presentations. VIVA uses innovative technology to bring “the newest, latest, and greatest information to practitioners across the spectrum,” says Dr. Joshua Beckman, VIVA Physicians board member. “We are agnostic to your specialty type, but we are particular to your specialty ability.”</p>\n<p>VIVA will be held November 5-8, 2018, at the Wynn Las Vegas. Registration opens Spring 2018. Visit <a href=\"http://www.vivaphysicians.org/\">www.vivaphysicians.org</a> for more information.</p>\n<h3><strong>The VEINS at VIVA in Its 4</strong><strong>th</strong><strong> Year</strong></h3>\n<p>The VEINS (Venous Endovascular INterventional Strategies) at VIVA symposium has expanded to 2 full days in 2018 to provide more time to explore the treatment and challenges of venous thromboembolism diseases.</p>\n<p>Pulmonary embolism treatment, controversies in VTE management, and breaking data on deep venous intervention will headline the course. Also of focus will be the growing success and importance of Pulmonary Embolism Response Teams (PERT), along with sessions on wound care and diagnosis and management strategies for superficial venous disease.</p>\n<p>The VEINS at VIVA 18 will bring an in-depth look into the rapidly evolving field of venous disease medicine. Course directors Dr. Raghu Kolluri and Dr. John Kaufman will head up a multidisciplinary faculty as they present a comprehensive analysis of critical issues facing today’s vascular specialists.</p>\n<p>The VEINS at VIVA will be held November 4-5, 2018, at the Wynn Las Vegas. Registration opens Spring 2018. Visit <a href=\"http://www.vivaphysicians.org/\">www.vivaphysicians.org</a> for more information.</p>', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, '2018-02-04 22:05:25', '2018-02-09 01:11:53', '01f86b35-c47b-4177-9a62-806d6b730540'),
 ('91', '91', 'en_us', 'There is a Lot More to Know About Managing Pulmonary Emboli', '<p><b>Michael R. Jaff, DO, and Kenneth Rosenfield, MD</b></p>\n<p><b>Vascular Medicine, Massachusetts General Hospital, Boston</b></p>\n<p>We know a lot about pulmonary emboli (PE). We know that that, though the risk for PE increases with each decade over the age of 40 (1), there is no adult patient population that is immune to the potentially devastating manifestations of PE. From a recent review of the risk of venous thromboemboli during or following prolonged air travel, we know that patients with one or more risk factors for PE should wear graduated compression stockings, avoid dehydration and be considered for pharmacoprophylaxis (2).</p>\n<p>From the guidelines of our medical societies, we have recommendations for treatment of PE in many scenarios. For example, the American College of Chest Physicians recently updated its guidelines to recommend systemic thrombolytic therapy over catheter-based therapy for patients with only PE and hypotension (3), and the European Society of Cardiology recommends “primary reperfusion” for the treatment of PE patients at high- and intermediate-high risk (4). Recent data support the use of systemic thrombolytic therapy for PE (5). We’ve learned so much that today there is little debate about the management of hemodynamically stable, minimally symptomatic PE patients. For these patients, the only controversy is which anticoagulant is most appropriate.</p>\n<p>So, yes, we know a lot. Unfortunately, there’s a lot we still need to learn.</p>\n<p><a href=\"http://viva365.org/wp-content/uploads/2016/05/PERT-2015.jpg\" class=\"image-popup\"><img class=\"size-large wp-image-511 aligncenter\" src=\"http://viva365.org/wp-content/uploads/2016/05/PERT-2015-1024x680.jpg\" alt=\"PERT 2015\" width=\"746\" height=\"495\" style=\"margin:10px auto 20px;padding:6px;border-width:1px;border-style:solid;border-color:rgb(226,226,226);height:auto;clear:both;\" /></a></p>\n<p>For starters, we don’t know the best treatment for “submassive” or “massive” PE. The options for treating these patients are almost as numerous as the opinions of the specialists who contribute to managing these conditions. We know about the challenges: bleeding risk; the often devastating impact of PE on long-term survival; the costs associated with advanced PE therapies; and that our institutions, many of them already stretched thin, struggle to identify patients who might have PE and then to perform rapid and definitive tests and treatments for those who present during “off-hours.”</p>\n<p>From our successes with acute myocardial infarction (STEMI) and stroke teams, we know that the key to successfully reducing morbidity and mortality from PE likely lies in learning how to improve our systems so that we rapidly deploy the right team of providers at the right time. Pulmonary Embolus Response Teams (PERT) have been described as a means to achieve that goal (6), and data regarding patient management within an institution offering care through such teams has been published (7).</p>\n<p><a href=\"http://viva365.org/wp-content/uploads/2016/05/Pert-2015-2.jpg\" class=\"image-popup\"><img class=\"size-large wp-image-510 aligncenter\" src=\"http://viva365.org/wp-content/uploads/2016/05/Pert-2015-2-1024x680.jpg\" alt=\"Pert 2015 2\" width=\"746\" height=\"495\" style=\"margin:10px auto 20px;padding:6px;border-width:1px;border-style:solid;border-color:rgb(226,226,226);height:auto;clear:both;\" /></a></p>\n<p>However, as skeptics have suggested, we don’t know enough about the costs of running PERT programs. We don’t yet know if risks ensue when such programs are dominated by specialists who perform PE interventions. Despite the demonstrated benefits of acute stroke and STEMI teams, we don’t yet have enough data to confirm the value of PERT programs.</p>\n<p>Again, there’s a lot we don’t know, and therefore, there’s a lot for us to debate. If you manage PE patients, please join us at the Massachusetts General Fireman Vascular CME Symposium on Pulmonary Embolism on June 28-29, 2016. There, you will see world-renowned experts coming come together to examine what we know and what we don’t know, and to debate the knowledge gaps and how best to fill them.</p>\n<p>Yes, there’s a lot we don’t know about this all-too-common and potentially deadly condition. Let’s change that. Visit <a href=\"http://www.pertconsortium.org/\">www.pertconsortium.org</a>.</p>\n<h2>REFERENCES</h2>\n<ol><li>Raskob GE, Angchaisuksiri P, Blanco AN, et al. Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol 2014;34:2363-71.</li><li>Philbrick JT, Shumate R, Siadaty MS, Becker DM. Air travel and venous thromboembolism: a systematic review. J Gen Intern Med 2007;22:107-114.</li><li>Kearon C, Aki EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST Guideline and expert panel report. Chest 2016;149:315-52.</li><li>Konstantinides SV, Torbick A, Agnelli G, et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. 2014;33:3033-80.</li><li>Chatterjee S, Chakraborty A, Weinberg I, et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage. A meta-analysis.  JAMA 2014;311:2414-21.</li><li>Kabrhel C, Jaff MR, Channick R, Baker J, Rosenfield K. A multidisciplinary pulmonary embolism response team. Chest 2013;144:1738-9.</li><li>Kabhrel C, Rosovsky R, Channick R, et al. A multispecialty pulmonary embolism response team (PERT)—initial 30-month experience with a novel approach to delivery of care to patients with sub-massive and massive PE. Chest 2016;March 19. ePub ahead of print.</li></ol>', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, '2018-02-04 22:28:36', '2018-02-05 18:25:31', '71775fa0-b9fb-44b9-9c94-f0d44d17fcc5'),
 ('92', '92', 'en_us', 'Edoxaban in venous thromboembolism: Clinical considerations', '<p>Edoxaban (Marketed as Savaysa, Daiichi Sankyo, Tokyo), an oral, once-daily factor Xa inhibitor, was approved by the FDA on January 8, 2015 for the prevention of stroke and systemic embolism in non-valvular atrial fibrillation and for the treatment of venous thromboembolism (VTE).</p>\n<p>In a <a href=\"http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm429523.htm\">press release</a> issued by the FDA, the U.S. Food and Drug Administration outlined a few reservations regarding the use of edoxaban:</p>\n<ul><li>In non-valvular atrial fibrillation, patients with creatinine clearance greater than 95 ml/min had an increased rate of ischemic stroke with edoxaban as compared to warfarin. Such data does not exist regarding VTE. As part of its label, edoxaban carries a boxed warning stating that edoxaban should not be used  in non-valvular atrial fibrillation patients with creatinine clearance greater than 95 ml/min for the prevention of stroke.</li><li>For the treatment of VTE, edoxaban is only approved after a parenteral agent has been administered for 5-10 days.</li></ul>\n<p>The approval for the use of edoxaban in patients with non-valvular atrial fibrillation is based on the <a href=\"http://www.nejm.org/doi/full/10.1056/NEJMoa1310907\">ENGAGE AF-TIMI 48 study</a> of 21,105 participants, published in the <em>New England Journal of Medicine</em> in November 2013.  This trial compared two doses of edoxaban to warfarin and revealed that the higher dose of edoxaban was non inferior to warfarin in the prevention of stroke and systemic embolism, 1.18% and 1.5%, respectively. Edoxaban demonstrated significantly less major bleeding and lower rates of intracranial hemorrhage compared to warfarin. However, there was a significant increase in gastrointestinal bleeding events with edoxaban versus warfarin.</p>\n<p>The recommended dose of edoxaban for non-valvular atrial fibrillation is 60 mg once daily. Creatinine clearance should be assessed before initiating therapy with edoxaban.  In patients with creatinine clearance between 15 ml/min and 50 ml/min, the dose should be reduced to 30 mg daily.  It is important to note that edoxaban has not been studied in patients with mechanical heart valves or moderate or severe mitral stenosis, and therefore, it is not recommended in these patients.  As with any anticoagulant, the premature discontinuation of edoxaban in the absence of alternative anticoagulation can increase the risk of ischemic events.</p>\n<p>The approval for use in venous thromboembolism patients was based on the <a href=\"http://www.nejm.org/doi/pdf/10.1056/NEJMoa1306638\">Hokusai venous thromboembolism study</a> published in the <em>New England Journal of Medicine</em> in October 2013. This study randomized 8,292 patients with DVT or PE to receive warfarin or edoxaban. Edoxaban was non-inferior to warfarin in reducing the rates of recurrent VTE, 3.2% versus 3.5%, respectively.  Edoxaban was also associated with a significant decrease in the primary safety outcome of first or clinically relevant nonmajor bleeding compared to warfarin, 8.5% vs 10.3%, respectively (p=0.004).   For patients with normal renal function, the recommended dose of edoxaban is 60 mg once daily following 5-10 days of a parenteral anticoagulant. For patients with a creatinine clearance between 30 mL/min and 50 mL/min, who weigh less than or equal to 60 kg, or who are on concomitant p-glycoprotein inhibitors, the recommended dose of edoxaban is 30 mg once daily following a parenteral anticoagulant.</p>\n<p>Two important points were noted as part of the Hokusai-VTE study that may set edoxaban apart from other new oral anticoagulants:</p>\n<ul><li>Use of a parenteral agent. Because the Hokusai-VTE trial included a run-in phase with a parenteral agent (unfractionated heparin or enoxaparin), edoxaban is not approved without the use of a parenteral agent for the first 5-10 days.  This is in contrast to both <a href=\"http://www.xareltohcp.com/sites/default/files/pdf/xarelto_0.pdf\">rivaroxaban</a> and <a href=\"http://packageinserts.bms.com/pi/pi_eliquis.pdf\">apixaban</a>, two other oral Xa inhibitors.</li><li>Use in severe pulmonary embolism. While rivaroxaban, apixaban and dabigatran have been poorly studied in the setting of high-risk pulmonary embolism, there is some data to suggest that edoxaban is effective in this subset of patients. RV dysfunction was found in over 34% in both the edoxaban and warfarin groups.  The authors speculated that the run-in with a parenteral agent encouraged clinicians to enroll patients with severe VTE edoxaban more frequently than in the other novel oral anticoagulant studies</li><li>Less clinically relevant bleeding than warfarin. There was a signal that showed superiority for clinically relevant bleeding (major and minor). This signal did not exist for the analysis examining major bleeding alone. A <a href=\"http://circ.ahajournals.org/content/131/1/82.full.pdf\">small phase I trial</a>published in January 2015 in <em>Circulation</em> showed that bleeding measures could be reversed by administration of 4 factor prothrombin complex concentrate (4F-PCC) in patients who received edoxaban. A <a href=\"http://www.bloodjournal.org/content/124/15/2450.full-text.pdf+html\">meta-analysis</a> showed that novel oral anticoagulants in general are associated with less bleeding than warfarin including less intra-cranial bleeding. This meta-analysis did not comment about edoxaban in particular. In a <a href=\"http://www.nejm.org/doi/full/10.1056/NEJMc1411800\">Phase I study</a>, published in the New England Journal of Medicine in Nov 2014, PER977 (Perosphere), a small, synthetic, water-soluble, cationic molecule designed to bind specifically to unfractionated heparin and low-molecular-weight heparin has shown promise as a reversal agent and is being investigated in ongoing Phase II trials.</li></ul>', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, '2018-02-04 22:28:55', '2018-02-05 18:26:52', 'b1f2a364-aff8-4c01-8039-b4a086807a75');



DROP TABLE IF EXISTS `craft_deprecationerrors`;


--
-- Schema for table `craft_deprecationerrors`
--
CREATE TABLE `craft_deprecationerrors` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `key` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `fingerprint` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `lastOccurrence` datetime NOT NULL,
  `file` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `line` smallint(6) unsigned NOT NULL,
  `class` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `method` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `template` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `templateLine` smallint(6) unsigned DEFAULT NULL,
  `message` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `traces` text COLLATE utf8_unicode_ci,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_deprecationerrors_key_fingerprint_unq_idx` (`key`,`fingerprint`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_elementindexsettings`;


--
-- Schema for table `craft_elementindexsettings`
--
CREATE TABLE `craft_elementindexsettings` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `type` varchar(150) COLLATE utf8_unicode_ci NOT NULL,
  `settings` text COLLATE utf8_unicode_ci,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_elementindexsettings_type_unq_idx` (`type`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_elements`;


--
-- Schema for table `craft_elements`
--
CREATE TABLE `craft_elements` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `type` varchar(150) COLLATE utf8_unicode_ci NOT NULL,
  `enabled` tinyint(1) unsigned NOT NULL DEFAULT '1',
  `archived` tinyint(1) unsigned NOT NULL DEFAULT '0',
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  KEY `craft_elements_type_idx` (`type`),
  KEY `craft_elements_enabled_idx` (`enabled`),
  KEY `craft_elements_archived_dateCreated_idx` (`archived`,`dateCreated`)
) ENGINE=InnoDB AUTO_INCREMENT=93 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

--
-- Data for table `craft_elements`
--

INSERT INTO `craft_elements` (`id`, `type`, `enabled`, `archived`, `dateCreated`, `dateUpdated`, `uid`) VALUES
 ('1', 'User', '1', '0', '2018-01-24 18:37:16', '2018-02-03 17:48:05', '690fa433-5bd8-4765-ab21-1e82a1880324'),
 ('2', 'Entry', '1', '0', '2018-01-24 18:37:18', '2018-02-09 21:28:21', 'f2ee99cc-3c36-4e22-a643-ff05e2bc6a9e'),
 ('90', 'Entry', '1', '0', '2018-02-04 22:05:25', '2018-02-09 01:11:53', 'dfcbd25c-b15e-4c47-8e31-d52e6266b533'),
 ('91', 'Entry', '1', '0', '2018-02-04 22:28:36', '2018-02-05 18:25:31', '79656b6b-688b-4524-9e3d-6a9a39544a6e'),
 ('92', 'Entry', '1', '0', '2018-02-04 22:28:55', '2018-02-05 18:26:52', '2fc829bd-f381-46e1-8399-a31e61f5c28d');



DROP TABLE IF EXISTS `craft_elements_i18n`;


--
-- Schema for table `craft_elements_i18n`
--
CREATE TABLE `craft_elements_i18n` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `elementId` int(11) NOT NULL,
  `locale` char(12) COLLATE utf8_unicode_ci NOT NULL,
  `slug` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `uri` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `enabled` tinyint(1) unsigned NOT NULL DEFAULT '1',
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_elements_i18n_elementId_locale_unq_idx` (`elementId`,`locale`),
  UNIQUE KEY `craft_elements_i18n_uri_locale_unq_idx` (`uri`,`locale`),
  KEY `craft_elements_i18n_slug_locale_idx` (`slug`,`locale`),
  KEY `craft_elements_i18n_enabled_idx` (`enabled`),
  KEY `craft_elements_i18n_locale_fk` (`locale`)
) ENGINE=InnoDB AUTO_INCREMENT=93 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

--
-- Data for table `craft_elements_i18n`
--

INSERT INTO `craft_elements_i18n` (`id`, `elementId`, `locale`, `slug`, `uri`, `enabled`, `dateCreated`, `dateUpdated`, `uid`) VALUES
 ('1', '1', 'en_us', '', NULL, '1', '2018-01-24 18:37:16', '2018-02-03 17:48:05', '79240e9f-325f-4297-8257-80e84c981d2a'),
 ('2', '2', 'en_us', 'homepage', '__home__', '1', '2018-01-24 18:37:18', '2018-02-09 21:28:21', 'dd2ed043-3100-45ea-8c21-e1af820bad5a'),
 ('90', '90', 'en_us', 'viva-continues-its-focus-on-multidisciplinary-education', 'news/2017/viva-continues-its-focus-on-multidisciplinary-education', '1', '2018-02-04 22:05:25', '2018-02-09 01:11:53', 'c112ed85-579f-400d-af99-db032888f831'),
 ('91', '91', 'en_us', 'there-is-a-lot-more-to-know-about-managing-pulmonary-emboli', 'news/2016/there-is-a-lot-more-to-know-about-managing-pulmonary-emboli', '1', '2018-02-04 22:28:36', '2018-02-05 18:25:31', '998e6773-f358-4896-b154-7662d8d87aa6'),
 ('92', '92', 'en_us', 'edoxaban-in-venous-thromboembolism-clinical-considerations', 'news/2015/edoxaban-in-venous-thromboembolism-clinical-considerations', '1', '2018-02-04 22:28:55', '2018-02-05 18:26:52', 'f1c5a1fd-4d7a-4e2a-a14c-81a08e27589e');



DROP TABLE IF EXISTS `craft_emailmessages`;


--
-- Schema for table `craft_emailmessages`
--
CREATE TABLE `craft_emailmessages` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `key` char(150) COLLATE utf8_unicode_ci NOT NULL,
  `locale` char(12) COLLATE utf8_unicode_ci NOT NULL,
  `subject` varchar(1000) COLLATE utf8_unicode_ci NOT NULL,
  `body` text COLLATE utf8_unicode_ci NOT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_emailmessages_key_locale_unq_idx` (`key`,`locale`),
  KEY `craft_emailmessages_locale_fk` (`locale`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_entries`;


--
-- Schema for table `craft_entries`
--
CREATE TABLE `craft_entries` (
  `id` int(11) NOT NULL,
  `sectionId` int(11) NOT NULL,
  `typeId` int(11) DEFAULT NULL,
  `authorId` int(11) DEFAULT NULL,
  `postDate` datetime DEFAULT NULL,
  `expiryDate` datetime DEFAULT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  KEY `craft_entries_sectionId_idx` (`sectionId`),
  KEY `craft_entries_typeId_idx` (`typeId`),
  KEY `craft_entries_postDate_idx` (`postDate`),
  KEY `craft_entries_expiryDate_idx` (`expiryDate`),
  KEY `craft_entries_authorId_fk` (`authorId`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

--
-- Data for table `craft_entries`
--

INSERT INTO `craft_entries` (`id`, `sectionId`, `typeId`, `authorId`, `postDate`, `expiryDate`, `dateCreated`, `dateUpdated`, `uid`) VALUES
 ('2', '1', NULL, NULL, '2018-01-24 18:37:18', NULL, '2018-01-24 18:37:18', '2018-02-09 21:28:21', 'd8c1850e-04d2-434d-9f68-a8be96292c22'),
 ('90', '2', '2', '1', '2017-12-01 22:05:00', NULL, '2018-02-04 22:05:25', '2018-02-09 01:11:53', 'd86e7d01-3031-4077-b64e-ec212d685a72'),
 ('91', '2', '2', '1', '2016-05-18 22:28:00', NULL, '2018-02-04 22:28:36', '2018-02-05 18:25:31', 'b5f0cb7c-0315-415e-8100-0e27ebe6eacc'),
 ('92', '2', '2', '1', '2015-01-10 22:28:00', NULL, '2018-02-04 22:28:55', '2018-02-05 18:26:52', 'ca672120-1797-4a15-982f-02faa696a5a0');



DROP TABLE IF EXISTS `craft_entrydrafts`;


--
-- Schema for table `craft_entrydrafts`
--
CREATE TABLE `craft_entrydrafts` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `entryId` int(11) NOT NULL,
  `sectionId` int(11) NOT NULL,
  `creatorId` int(11) NOT NULL,
  `locale` char(12) COLLATE utf8_unicode_ci NOT NULL,
  `name` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `notes` tinytext COLLATE utf8_unicode_ci,
  `data` mediumtext COLLATE utf8_unicode_ci NOT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  KEY `craft_entrydrafts_entryId_locale_idx` (`entryId`,`locale`),
  KEY `craft_entrydrafts_sectionId_fk` (`sectionId`),
  KEY `craft_entrydrafts_creatorId_fk` (`creatorId`),
  KEY `craft_entrydrafts_locale_fk` (`locale`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_entrytypes`;


--
-- Schema for table `craft_entrytypes`
--
CREATE TABLE `craft_entrytypes` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `sectionId` int(11) NOT NULL,
  `fieldLayoutId` int(11) DEFAULT NULL,
  `name` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `handle` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `hasTitleField` tinyint(1) unsigned NOT NULL DEFAULT '1',
  `titleLabel` varchar(255) COLLATE utf8_unicode_ci DEFAULT 'Title',
  `titleFormat` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `sortOrder` smallint(6) unsigned DEFAULT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_entrytypes_name_sectionId_unq_idx` (`name`,`sectionId`),
  UNIQUE KEY `craft_entrytypes_handle_sectionId_unq_idx` (`handle`,`sectionId`),
  KEY `craft_entrytypes_sectionId_fk` (`sectionId`),
  KEY `craft_entrytypes_fieldLayoutId_fk` (`fieldLayoutId`)
) ENGINE=InnoDB AUTO_INCREMENT=3 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

--
-- Data for table `craft_entrytypes`
--

INSERT INTO `craft_entrytypes` (`id`, `sectionId`, `fieldLayoutId`, `name`, `handle`, `hasTitleField`, `titleLabel`, `titleFormat`, `sortOrder`, `dateCreated`, `dateUpdated`, `uid`) VALUES
 ('1', '1', '8', 'Homepage', 'homepage', '1', 'Title', NULL, '1', '2018-01-24 18:37:18', '2018-02-09 21:32:21', '01c3fbe2-73ab-4c35-8a88-454e9e652f10'),
 ('2', '2', '5', 'News', 'news', '1', 'Title', NULL, '1', '2018-01-24 18:37:18', '2018-01-24 18:37:18', '0a029de2-0cae-4a4b-90f8-dd43a0f78d4b');



DROP TABLE IF EXISTS `craft_entryversions`;


--
-- Schema for table `craft_entryversions`
--
CREATE TABLE `craft_entryversions` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `entryId` int(11) NOT NULL,
  `sectionId` int(11) NOT NULL,
  `creatorId` int(11) DEFAULT NULL,
  `locale` char(12) COLLATE utf8_unicode_ci NOT NULL,
  `num` smallint(6) unsigned NOT NULL,
  `notes` tinytext COLLATE utf8_unicode_ci,
  `data` mediumtext COLLATE utf8_unicode_ci NOT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  KEY `craft_entryversions_entryId_locale_idx` (`entryId`,`locale`),
  KEY `craft_entryversions_sectionId_fk` (`sectionId`),
  KEY `craft_entryversions_creatorId_fk` (`creatorId`),
  KEY `craft_entryversions_locale_fk` (`locale`)
) ENGINE=InnoDB AUTO_INCREMENT=13 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

--
-- Data for table `craft_entryversions`
--

INSERT INTO `craft_entryversions` (`id`, `entryId`, `sectionId`, `creatorId`, `locale`, `num`, `notes`, `data`, `dateCreated`, `dateUpdated`, `uid`) VALUES
 ('1', '2', '1', '1', 'en_us', '1', NULL, '{\"typeId\":\"1\",\"authorId\":null,\"title\":\"Homepage\",\"slug\":\"homepage\",\"postDate\":1516819038,\"expiryDate\":null,\"enabled\":1,\"parentId\":null,\"fields\":[]}', '2018-01-24 18:37:18', '2018-01-24 18:37:18', 'bf4fe062-827b-47e4-afeb-238b3c8a3547'),
 ('2', '2', '1', '1', 'en_us', '2', NULL, '{\"typeId\":null,\"authorId\":null,\"title\":\"Welcome to Ec2-54-165-224-216.compute-1.amazonaws.com!\",\"slug\":\"homepage\",\"postDate\":1516819038,\"expiryDate\":null,\"enabled\":\"1\",\"parentId\":null,\"fields\":{\"1\":\"<p>It\\u2019s true, this site doesn\\u2019t have a whole lot of content yet, but don\\u2019t worry. Our web developers have just installed the CMS, and they\\u2019re setting things up for the content editors this very moment. Soon Ec2-54-165-224-216.compute-1.amazonaws.com will be an oasis of fresh perspectives, sharp analyses, and astute opinions that will keep you coming back again and again.<\\/p>\"}}', '2018-01-24 18:37:18', '2018-01-24 18:37:18', '3a1812f8-f618-4514-97fe-d35059c278fd'),
 ('4', '90', '2', '1', 'en_us', '1', '', '{\"typeId\":null,\"authorId\":\"1\",\"title\":\"VIVA Continues Its Focus on Multidisciplinary Education\",\"slug\":\"viva-continues-its-focus-on-multidisciplinary-education\",\"postDate\":1517781925,\"expiryDate\":null,\"enabled\":1,\"parentId\":null,\"fields\":{\"1\":\"<p>Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla ex nunc, aliquet id sodales id, pellentesque sed odio. Nunc vitae dui risus. Nullam congue vehicula tellus. Nulla venenatis odio non condimentum hendrerit. Proin scelerisque augue id risus egestas blandit ut non metus. Suspendisse in varius sem, ac tristique turpis. In hac habitasse platea dictumst. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Duis mollis ex ut leo rutrum, eu tincidunt ex hendrerit. Integer non odio lectus. Fusce purus sem, volutpat eget condimentum tincidunt, dapibus quis dolor. Etiam porta lacinia elit consectetur tincidunt.<\\/p>\\r\\n<p>Pellentesque aliquam ligula vitae massa bibendum aliquam. Sed ante erat, convallis sit amet mollis id, elementum quis tellus. Mauris commodo ex vel odio facilisis, nec elementum erat ullamcorper. Mauris et malesuada elit. In ac dictum sapien, a iaculis massa. Donec rhoncus, dui eget condimentum dapibus, nisl est hendrerit libero, sit amet mattis ex felis a purus. Integer nec nisl in dui gravida fermentum. Cras sapien lectus, placerat a tellus quis, tempor euismod elit. In vehicula purus id ante blandit faucibus. Aliquam fermentum mattis risus a efficitur. Vestibulum nibh arcu, pretium at malesuada vel, interdum eget ex. Quisque lectus ex, tempor sed mollis a, mattis quis urna. Morbi sodales vitae quam ac bibendum.<\\/p>\",\"2\":\"\"}}', '2018-02-04 22:05:25', '2018-02-04 22:05:25', '4abefc9b-d5d6-4ded-8ce5-e3f11fb27f93'),
 ('5', '91', '2', '1', 'en_us', '1', '', '{\"typeId\":null,\"authorId\":\"1\",\"title\":\"There is a Lot More to Know About Managing Pulmonary Emboli\",\"slug\":\"there-is-a-lot-more-to-know-about-managing-pulmonary-emboli\",\"postDate\":1517783316,\"expiryDate\":null,\"enabled\":1,\"parentId\":null,\"fields\":{\"1\":\"<p>Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla ex nunc, aliquet id sodales id, pellentesque sed odio. Nunc vitae dui risus. Nullam congue vehicula tellus. Nulla venenatis odio non condimentum hendrerit. Proin scelerisque augue id risus egestas blandit ut non metus. Suspendisse in varius sem, ac tristique turpis. In hac habitasse platea dictumst. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Duis mollis ex ut leo rutrum, eu tincidunt ex hendrerit. Integer non odio lectus. Fusce purus sem, volutpat eget condimentum tincidunt, dapibus quis dolor. Etiam porta lacinia elit consectetur tincidunt.<\\/p>\\r\\n<p>Pellentesque aliquam ligula vitae massa bibendum aliquam. Sed ante erat, convallis sit amet mollis id, elementum quis tellus. Mauris commodo ex vel odio facilisis, nec elementum erat ullamcorper. Mauris et malesuada elit. In ac dictum sapien, a iaculis massa. Donec rhoncus, dui eget condimentum dapibus, nisl est hendrerit libero, sit amet mattis ex felis a purus. Integer nec nisl in dui gravida fermentum. Cras sapien lectus, placerat a tellus quis, tempor euismod elit. In vehicula purus id ante blandit faucibus. Aliquam fermentum mattis risus a efficitur. Vestibulum nibh arcu, pretium at malesuada vel, interdum eget ex. Quisque lectus ex, tempor sed mollis a, mattis quis urna. Morbi sodales vitae quam ac bibendum.<\\/p>\",\"2\":\"\"}}', '2018-02-04 22:28:36', '2018-02-04 22:28:36', '3e6e65a7-e6dc-44b5-a696-a24f2a8349e0'),
 ('6', '92', '2', '1', 'en_us', '1', '', '{\"typeId\":null,\"authorId\":\"1\",\"title\":\"Edoxaban in venous thromboembolism: Clinical considerations\",\"slug\":\"edoxaban-in-venous-thromboembolism-clinical-considerations\",\"postDate\":1517783335,\"expiryDate\":null,\"enabled\":1,\"parentId\":null,\"fields\":{\"1\":\"<p>Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla ex nunc, aliquet id sodales id, pellentesque sed odio. Nunc vitae dui risus. Nullam congue vehicula tellus. Nulla venenatis odio non condimentum hendrerit. Proin scelerisque augue id risus egestas blandit ut non metus. Suspendisse in varius sem, ac tristique turpis. In hac habitasse platea dictumst. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Duis mollis ex ut leo rutrum, eu tincidunt ex hendrerit. Integer non odio lectus. Fusce purus sem, volutpat eget condimentum tincidunt, dapibus quis dolor. Etiam porta lacinia elit consectetur tincidunt.<\\/p>\\r\\n<p>Pellentesque aliquam ligula vitae massa bibendum aliquam. Sed ante erat, convallis sit amet mollis id, elementum quis tellus. Mauris commodo ex vel odio facilisis, nec elementum erat ullamcorper. Mauris et malesuada elit. In ac dictum sapien, a iaculis massa. Donec rhoncus, dui eget condimentum dapibus, nisl est hendrerit libero, sit amet mattis ex felis a purus. Integer nec nisl in dui gravida fermentum. Cras sapien lectus, placerat a tellus quis, tempor euismod elit. In vehicula purus id ante blandit faucibus. Aliquam fermentum mattis risus a efficitur. Vestibulum nibh arcu, pretium at malesuada vel, interdum eget ex. Quisque lectus ex, tempor sed mollis a, mattis quis urna. Morbi sodales vitae quam ac bibendum.<\\/p>\",\"2\":\"\"}}', '2018-02-04 22:28:55', '2018-02-04 22:28:55', 'a2d4cb83-3f4e-4138-9e70-9c55061d9baa'),
 ('7', '90', '2', '1', 'en_us', '2', '', '{\"typeId\":\"2\",\"authorId\":\"1\",\"title\":\"VIVA Continues Its Focus on Multidisciplinary Education\",\"slug\":\"viva-continues-its-focus-on-multidisciplinary-education\",\"postDate\":1512165900,\"expiryDate\":null,\"enabled\":1,\"parentId\":null,\"fields\":{\"1\":\"<p>As the field of vascular medicine rapidly evolves, VIVA (Vascular InterVentional Advances) continues to be at the forefront of interactive, multispecialty education. Now in its 16th year, this annual conference offers attendees the opportunity to hear distinguished speakers in the vascular medicine field discuss the most relevant issues. VIVA\\u2019s hot topics for 2018 include complications management, critical limb ischemia, pharmacotherapy, a special session on disruptive technologies, and more.<\\/p>\\r\\n<p>As VIVA Physicians Board President Dr. John Kaufman notes, \\u201cIt\\u2019s difficult for a practitioner to sift through new information to understand what\\u2019s important. VIVA is structured to provide you with that analysis, that critical view of the data and information, in a compact way from multiple specialists.\\u201d VIVA\\u2019s faculty and attendees provide representation from interventional cardiology, interventional radiology, vascular and cardiothoracic surgery, and vascular medicine. The benefit of this is that \\u201cyou won\\u2019t get just the party line from one group of individuals,\\u201d Kaufman says. \\u201cYou\\u2019ll hear from everybody in a distilled manner&mdash;what\\u2019s important and what you need to know going forward.\\u201d<\\/p>\\r\\n<p>VIVA offers vascular medicine practitioners of all levels a chance to interact with speakers and attendees through a variety of educational formats. For fellows and physicians-in-training there are presentations on finding and succeeding in a first job, the importance of achieving an optimal work-life balance, and guidance on making contributions in the field.<\\/p>\\r\\n<p>Additionally, attendees can leverage the power of the Virtual VIVA app to interact with faculty, view live cases, and review presentations. VIVA uses innovative technology to bring \\u201cthe newest, latest, and greatest information to practitioners across the spectrum,\\u201d says Dr. Joshua Beckman, VIVA Physicians board member. \\u201cWe are agnostic to your specialty type, but we are particular to your specialty ability.\\u201d<\\/p>\\r\\n<p>VIVA will be held November 5-8, 2018, at the Wynn Las Vegas. Registration opens Spring 2018. Visit <a href=\\\"http:\\/\\/www.vivaphysicians.org\\/\\\">www.vivaphysicians.org<\\/a> for more information.<\\/p>\\r\\n<h2><b>The VEINS at VIVA in Its 4<\\/b><b>th<\\/b><b> Year<\\/b><\\/h2>\\r\\n<p>The VEINS (Venous Endovascular INterventional Strategies) at VIVA symposium has expanded to 2 full days in 2018 to provide more time to explore the treatment and challenges of venous thromboembolism diseases.<\\/p>\\r\\n<p>Pulmonary embolism treatment, controversies in VTE management, and breaking data on deep venous intervention will headline the course. Also of focus will be the growing success and importance of Pulmonary Embolism Response Teams (PERT), along with sessions on wound care and diagnosis and management strategies for superficial venous disease.<\\/p>\\r\\n<p>The VEINS at VIVA 18 will bring an in-depth look into the rapidly evolving field of venous disease medicine. Course directors Dr. Raghu Kolluri and Dr. John Kaufman will head up a multidisciplinary faculty as they present a comprehensive analysis of critical issues facing today\\u2019s vascular specialists.<\\/p>\\r\\n<p>The VEINS at VIVA will be held November 4-5, 2018, at the Wynn Las Vegas. Registration opens Spring 2018. Visit <a href=\\\"http:\\/\\/www.vivaphysicians.org\\/\\\">www.vivaphysicians.org<\\/a> for more information.<\\/p>\\r\\n<p><\\/p><p><\\/p>\",\"2\":\"\"}}', '2018-02-05 18:23:23', '2018-02-05 18:23:23', 'c662950b-799b-4e47-820b-0a45eb6d7363'),
 ('8', '90', '2', '1', 'en_us', '3', '', '{\"typeId\":\"2\",\"authorId\":\"1\",\"title\":\"VIVA Continues Its Focus on Multidisciplinary Education\",\"slug\":\"viva-continues-its-focus-on-multidisciplinary-education\",\"postDate\":1512165900,\"expiryDate\":null,\"enabled\":1,\"parentId\":null,\"fields\":{\"1\":\"<p>As the field of vascular medicine rapidly evolves, VIVA (Vascular InterVentional Advances) continues to be at the forefront of interactive, multispecialty education. Now in its 16th year, this annual conference offers attendees the opportunity to hear distinguished speakers in the vascular medicine field discuss the most relevant issues. VIVA\\u2019s hot topics for 2018 include complications management, critical limb ischemia, pharmacotherapy, a special session on disruptive technologies, and more.<\\/p>\\r\\n<p>As VIVA Physicians Board President Dr. John Kaufman notes, \\u201cIt\\u2019s difficult for a practitioner to sift through new information to understand what\\u2019s important. VIVA is structured to provide you with that analysis, that critical view of the data and information, in a compact way from multiple specialists.\\u201d VIVA\\u2019s faculty and attendees provide representation from interventional cardiology, interventional radiology, vascular and cardiothoracic surgery, and vascular medicine. The benefit of this is that \\u201cyou won\\u2019t get just the party line from one group of individuals,\\u201d Kaufman says. \\u201cYou\\u2019ll hear from everybody in a distilled manner&mdash;what\\u2019s important and what you need to know going forward.\\u201d<\\/p>\\r\\n<p>VIVA offers vascular medicine practitioners of all levels a chance to interact with speakers and attendees through a variety of educational formats. For fellows and physicians-in-training there are presentations on finding and succeeding in a first job, the importance of achieving an optimal work-life balance, and guidance on making contributions in the field.<\\/p>\\r\\n<p>Additionally, attendees can leverage the power of the Virtual VIVA app to interact with faculty, view live cases, and review presentations. VIVA uses innovative technology to bring \\u201cthe newest, latest, and greatest information to practitioners across the spectrum,\\u201d says Dr. Joshua Beckman, VIVA Physicians board member. \\u201cWe are agnostic to your specialty type, but we are particular to your specialty ability.\\u201d<\\/p>\\r\\n<p>VIVA will be held November 5-8, 2018, at the Wynn Las Vegas. Registration opens Spring 2018. Visit <a href=\\\"http:\\/\\/www.vivaphysicians.org\\/\\\">www.vivaphysicians.org<\\/a> for more information.<\\/p><p><\\/p>\\r\\n<h2><strong>The VEINS at VIVA in Its 4<\\/strong><strong>th<\\/strong><strong> Year<\\/strong><\\/h2>\\r\\n<p>The VEINS (Venous Endovascular INterventional Strategies) at VIVA symposium has expanded to 2 full days in 2018 to provide more time to explore the treatment and challenges of venous thromboembolism diseases.<\\/p>\\r\\n<p>Pulmonary embolism treatment, controversies in VTE management, and breaking data on deep venous intervention will headline the course. Also of focus will be the growing success and importance of Pulmonary Embolism Response Teams (PERT), along with sessions on wound care and diagnosis and management strategies for superficial venous disease.<\\/p>\\r\\n<p>The VEINS at VIVA 18 will bring an in-depth look into the rapidly evolving field of venous disease medicine. Course directors Dr. Raghu Kolluri and Dr. John Kaufman will head up a multidisciplinary faculty as they present a comprehensive analysis of critical issues facing today\\u2019s vascular specialists.<\\/p>\\r\\n<p>The VEINS at VIVA will be held November 4-5, 2018, at the Wynn Las Vegas. Registration opens Spring 2018. Visit <a href=\\\"http:\\/\\/www.vivaphysicians.org\\/\\\">www.vivaphysicians.org<\\/a> for more information.<\\/p>\",\"2\":\"\"}}', '2018-02-05 18:23:45', '2018-02-05 18:23:45', 'd815f314-f516-4d6a-9b3f-13a82b685eaf'),
 ('9', '91', '2', '1', 'en_us', '2', '', '{\"typeId\":\"2\",\"authorId\":\"1\",\"title\":\"There is a Lot More to Know About Managing Pulmonary Emboli\",\"slug\":\"there-is-a-lot-more-to-know-about-managing-pulmonary-emboli\",\"postDate\":1463610480,\"expiryDate\":null,\"enabled\":1,\"parentId\":null,\"fields\":{\"1\":\"<p><b>Michael R. Jaff, DO, and Kenneth Rosenfield, MD<\\/b><\\/p>\\r\\n<p><b>Vascular Medicine, Massachusetts General Hospital, Boston<\\/b><\\/p>\\r\\n<p>We know a lot about pulmonary emboli (PE). We know that that, though the risk for PE increases with each decade over the age of 40 (1), there is no adult patient population that is immune to the potentially devastating manifestations of PE. From a recent review of the risk of venous thromboemboli during or following prolonged air travel, we know that patients with one or more risk factors for PE should wear graduated compression stockings, avoid dehydration and be considered for pharmacoprophylaxis (2).<\\/p>\\r\\n<p>From the guidelines of our medical societies, we have recommendations for treatment of PE in many scenarios. For example, the American College of Chest Physicians recently updated its guidelines to recommend systemic thrombolytic therapy over catheter-based therapy for patients with only PE and hypotension (3), and the European Society of Cardiology recommends \\u201cprimary reperfusion\\u201d for the treatment of PE patients at high- and intermediate-high risk (4). Recent data support the use of systemic thrombolytic therapy for PE (5). We\\u2019ve learned so much that today there is little debate about the management of hemodynamically stable, minimally symptomatic PE patients. For these patients, the only controversy is which anticoagulant is most appropriate.<\\/p>\\r\\n<p>So, yes, we know a lot. Unfortunately, there\\u2019s a lot we still need to learn.<\\/p>\\r\\n<p><a href=\\\"http:\\/\\/viva365.org\\/wp-content\\/uploads\\/2016\\/05\\/PERT-2015.jpg\\\" class=\\\"image-popup\\\"><img class=\\\"size-large wp-image-511 aligncenter\\\" src=\\\"http:\\/\\/viva365.org\\/wp-content\\/uploads\\/2016\\/05\\/PERT-2015-1024x680.jpg\\\" alt=\\\"PERT 2015\\\" width=\\\"746\\\" height=\\\"495\\\" srcset=\\\"http:\\/\\/viva365.org\\/wp-content\\/uploads\\/2016\\/05\\/PERT-2015-1024x680.jpg 1024w, http:\\/\\/viva365.org\\/wp-content\\/uploads\\/2016\\/05\\/PERT-2015-300x199.jpg 300w, http:\\/\\/viva365.org\\/wp-content\\/uploads\\/2016\\/05\\/PERT-2015-768x510.jpg 768w, http:\\/\\/viva365.org\\/wp-content\\/uploads\\/2016\\/05\\/PERT-2015.jpg 1600w\\\" sizes=\\\"(max-width: 746px) 100vw, 746px\\\" style=\\\"margin: 10px auto 20px; padding: 6px; border-width: 1px; border-style: solid; border-color: rgb(226, 226, 226); outline: 0px; max-width: 95%; height: auto; display: block; clear: both; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-radius: 2px; box-shadow: rgb(209, 209, 209) 1px 2px 1px;\\\"><\\/a><\\/p>\\r\\n<p>For starters, we don\\u2019t know the best treatment for \\u201csubmassive\\u201d or \\u201cmassive\\u201d PE. The options for treating these patients are almost as numerous as the opinions of the specialists who contribute to managing these conditions. We know about the challenges: bleeding risk; the often devastating impact of PE on long-term survival; the costs associated with advanced PE therapies; and that our institutions, many of them already stretched thin, struggle to identify patients who might have PE and then to perform rapid and definitive tests and treatments for those who present during \\u201coff-hours.\\u201d<\\/p>\\r\\n<p>From our successes with acute myocardial infarction (STEMI) and stroke teams, we know that the key to successfully reducing morbidity and mortality from PE likely lies in learning how to improve our systems so that we rapidly deploy the right team of providers at the right time. Pulmonary Embolus Response Teams (PERT) have been described as a means to achieve that goal (6), and data regarding patient management within an institution offering care through such teams has been published (7).<\\/p>\\r\\n<p><a href=\\\"http:\\/\\/viva365.org\\/wp-content\\/uploads\\/2016\\/05\\/Pert-2015-2.jpg\\\" class=\\\"image-popup\\\"><img class=\\\"size-large wp-image-510 aligncenter\\\" src=\\\"http:\\/\\/viva365.org\\/wp-content\\/uploads\\/2016\\/05\\/Pert-2015-2-1024x680.jpg\\\" alt=\\\"Pert 2015 2\\\" width=\\\"746\\\" height=\\\"495\\\" srcset=\\\"http:\\/\\/viva365.org\\/wp-content\\/uploads\\/2016\\/05\\/Pert-2015-2-1024x680.jpg 1024w, http:\\/\\/viva365.org\\/wp-content\\/uploads\\/2016\\/05\\/Pert-2015-2-300x199.jpg 300w, http:\\/\\/viva365.org\\/wp-content\\/uploads\\/2016\\/05\\/Pert-2015-2-768x510.jpg 768w, http:\\/\\/viva365.org\\/wp-content\\/uploads\\/2016\\/05\\/Pert-2015-2.jpg 1600w\\\" sizes=\\\"(max-width: 746px) 100vw, 746px\\\" style=\\\"margin: 10px auto 20px; padding: 6px; border-width: 1px; border-style: solid; border-color: rgb(226, 226, 226); outline: 0px; max-width: 95%; height: auto; display: block; clear: both; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; border-radius: 2px; box-shadow: rgb(209, 209, 209) 1px 2px 1px;\\\"><\\/a><\\/p>\\r\\n<p>However, as skeptics have suggested, we don\\u2019t know enough about the costs of running PERT programs. We don\\u2019t yet know if risks ensue when such programs are dominated by specialists who perform PE interventions. Despite the demonstrated benefits of acute stroke and STEMI teams, we don\\u2019t yet have enough data to confirm the value of PERT programs.<\\/p>\\r\\n<p>Again, there\\u2019s a lot we don\\u2019t know, and therefore, there\\u2019s a lot for us to debate. If you manage PE patients, please join us at the Massachusetts General Fireman Vascular CME Symposium on Pulmonary Embolism on June 28-29, 2016. There, you will see world-renowned experts coming come together to examine what we know and what we don\\u2019t know, and to debate the knowledge gaps and how best to fill them.<\\/p>\\r\\n<p>Yes, there\\u2019s a lot we don\\u2019t know about this all-too-common and potentially deadly condition. Let\\u2019s change that. Visit&nbsp;<a href=\\\"http:\\/\\/www.pertconsortium.org\\/\\\">www.pertconsortium.org<\\/a>.<\\/p><p><\\/p>\\r\\n<h2>REFERENCES<\\/h2>\\r\\n<ol><li>Raskob GE, Angchaisuksiri P, Blanco AN, et al. Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol 2014;34:2363-71.<\\/li><li>Philbrick JT, Shumate R, Siadaty MS, Becker DM. Air travel and venous thromboembolism: a systematic review. J Gen Intern Med 2007;22:107-114.<\\/li><li>Kearon C, Aki EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST Guideline and expert panel report. Chest 2016;149:315-52.<\\/li><li>Konstantinides SV, Torbick A, Agnelli G, et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. 2014;33:3033-80.<\\/li><li>Chatterjee S, Chakraborty A, Weinberg I, et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage. A meta-analysis.&nbsp; JAMA 2014;311:2414-21.<\\/li><li>Kabrhel C, Jaff MR, Channick R, Baker J, Rosenfield K. A multidisciplinary pulmonary embolism response team. Chest 2013;144:1738-9.<\\/li><li>Kabhrel C, Rosovsky R, Channick R, et al. A multispecialty pulmonary embolism response team (PERT)&mdash;initial 30-month experience with a novel approach to delivery of care to patients with sub-massive and massive PE. Chest 2016;March 19. ePub ahead of print.<\\/li><\\/ol><p><\\/p>\",\"2\":\"\"}}', '2018-02-05 18:25:31', '2018-02-05 18:25:31', 'fb5c5b08-89f4-4e42-9295-e922eb646c52'),
 ('10', '92', '2', '1', 'en_us', '2', '', '{\"typeId\":\"2\",\"authorId\":\"1\",\"title\":\"Edoxaban in venous thromboembolism: Clinical considerations\",\"slug\":\"edoxaban-in-venous-thromboembolism-clinical-considerations\",\"postDate\":1420928880,\"expiryDate\":null,\"enabled\":1,\"parentId\":null,\"fields\":{\"1\":\"<p>Edoxaban (Marketed as Savaysa, Daiichi Sankyo, Tokyo), an oral, once-daily factor Xa inhibitor, was approved by the FDA on January 8, 2015 for the prevention of stroke and systemic embolism in non-valvular atrial fibrillation and for the treatment of venous thromboembolism (VTE).<\\/p>\\r\\n<p>In a&nbsp;<a href=\\\"http:\\/\\/www.fda.gov\\/newsevents\\/newsroom\\/pressannouncements\\/ucm429523.htm\\\">press release<\\/a>&nbsp;issued&nbsp;by the FDA, the U.S. Food and Drug Administration outlined a few reservations regarding the use of edoxaban:<\\/p>\\r\\n<ul><li>In non-valvular atrial fibrillation, patients with creatinine clearance greater than 95 ml\\/min had an increased rate of ischemic stroke with edoxaban as compared to warfarin. Such data does not exist regarding VTE. As part of its label, edoxaban carries a boxed warning stating that edoxaban should not be used &nbsp;in non-valvular atrial fibrillation patients with creatinine clearance greater than 95 ml\\/min for the prevention of stroke.<\\/li><li>For the treatment of VTE, edoxaban is only approved after a parenteral agent has been administered for 5-10 days.<\\/li><\\/ul>\\r\\n<p>The approval for the use of edoxaban in patients with non-valvular atrial fibrillation is based on the&nbsp;<a href=\\\"http:\\/\\/www.nejm.org\\/doi\\/full\\/10.1056\\/NEJMoa1310907\\\">ENGAGE AF-TIMI 48 study<\\/a>&nbsp;of 21,105 participants, published in the&nbsp;<em>New England Journal of Medicine<\\/em>&nbsp;in November 2013.&nbsp; This trial compared two doses of edoxaban to warfarin and revealed that the higher dose of edoxaban was non inferior to warfarin in the prevention of stroke and systemic embolism, 1.18% and 1.5%, respectively. Edoxaban demonstrated significantly less major bleeding and lower rates of intracranial hemorrhage compared to warfarin. However, there was a significant increase in gastrointestinal bleeding events with edoxaban versus warfarin.<\\/p>\\r\\n<p>The recommended dose of edoxaban for non-valvular atrial fibrillation is 60 mg once daily. Creatinine clearance should be assessed before initiating therapy with edoxaban.&nbsp; In patients with creatinine clearance between 15 ml\\/min and 50 ml\\/min, the dose should be reduced to 30 mg daily.&nbsp; It is important to note that edoxaban has not been studied in patients with mechanical heart valves or moderate or severe mitral stenosis, and therefore, it is not recommended in these patients.&nbsp; As with any anticoagulant, the premature discontinuation of edoxaban in the absence of alternative anticoagulation can increase the risk of ischemic events.<\\/p>\\r\\n<p>The approval for use in venous thromboembolism patients was based on the&nbsp;<a href=\\\"http:\\/\\/www.nejm.org\\/doi\\/pdf\\/10.1056\\/NEJMoa1306638\\\">Hokusai venous thromboembolism study<\\/a>&nbsp;published in the&nbsp;<em>New England Journal of Medicine<\\/em>&nbsp;in October 2013. This study randomized 8,292 patients with DVT or PE to receive warfarin or edoxaban. Edoxaban was non-inferior to warfarin in reducing the rates of recurrent VTE, 3.2% versus 3.5%, respectively.&nbsp; Edoxaban was also associated with a significant decrease in the primary safety outcome of first or clinically relevant nonmajor bleeding compared to warfarin, 8.5% vs 10.3%, respectively (p=0.004).&nbsp; &nbsp;For patients with normal renal function, the recommended dose of edoxaban is 60&nbsp;mg once daily following 5-10 days of a parenteral anticoagulant. For patients with a creatinine clearance between 30 mL\\/min and 50 mL\\/min, who weigh less than or equal to 60 kg, or who are on concomitant p-glycoprotein inhibitors, the recommended dose of edoxaban is 30 mg once daily following a parenteral anticoagulant.<\\/p>\\r\\n<p>Two important points were noted as part of the Hokusai-VTE study that may set edoxaban apart from other new oral anticoagulants:<\\/p>\\r\\n<ul><li>Use of a parenteral agent. Because the Hokusai-VTE trial included a run-in phase with a parenteral agent (unfractionated heparin or enoxaparin), edoxaban is not approved without the use of a parenteral agent for the first 5-10 days. &nbsp;This is in contrast to both&nbsp;<a href=\\\"http:\\/\\/www.xareltohcp.com\\/sites\\/default\\/files\\/pdf\\/xarelto_0.pdf\\\">rivaroxaban<\\/a>&nbsp;and&nbsp;<a href=\\\"http:\\/\\/packageinserts.bms.com\\/pi\\/pi_eliquis.pdf\\\">apixaban<\\/a>, two other oral Xa inhibitors.<\\/li><li>Use in severe pulmonary embolism. While rivaroxaban, apixaban and dabigatran have been poorly studied in the setting of high-risk pulmonary embolism, there is some data to suggest that edoxaban is effective in this subset of patients. RV dysfunction was found in over 34% in both the edoxaban and warfarin groups.&nbsp; The authors speculated that the run-in with a parenteral agent encouraged clinicians to enroll patients with severe VTE edoxaban more frequently than in the other novel oral anticoagulant studies<\\/li><li>Less clinically relevant bleeding than warfarin. There was a signal that showed superiority for clinically relevant bleeding (major and minor). This signal did not exist for the analysis examining major bleeding alone. A&nbsp;<a href=\\\"http:\\/\\/circ.ahajournals.org\\/content\\/131\\/1\\/82.full.pdf\\\">small phase I trial<\\/a>published in January 2015 in&nbsp;<em>Circulation<\\/em>&nbsp;showed that bleeding measures could be reversed by administration of 4 factor prothrombin complex concentrate (4F-PCC) in patients who received edoxaban. A&nbsp;<a href=\\\"http:\\/\\/www.bloodjournal.org\\/content\\/124\\/15\\/2450.full-text.pdf+html\\\">meta-analysis<\\/a>&nbsp;showed that novel oral anticoagulants in general are associated with less bleeding than warfarin including less intra-cranial bleeding. This meta-analysis did not comment about edoxaban in particular.&nbsp;In a&nbsp;<a href=\\\"http:\\/\\/www.nejm.org\\/doi\\/full\\/10.1056\\/NEJMc1411800\\\">Phase I study<\\/a>, published in the New England Journal of Medicine in Nov 2014, PER977 (Perosphere), a small, synthetic, water-soluble, cationic molecule designed to bind specifically to unfractionated heparin and low-molecular-weight heparin has shown promise as a reversal agent and is being investigated in ongoing Phase II trials.<\\/li><\\/ul>\",\"2\":\"\"}}', '2018-02-05 18:26:52', '2018-02-05 18:26:52', '6b90e2f6-11a2-4303-b7a3-131e2e9d63a3'),
 ('11', '90', '2', '1', 'en_us', '4', '', '{\"typeId\":\"2\",\"authorId\":\"1\",\"title\":\"VIVA Continues Its Focus on Multidisciplinary Education\",\"slug\":\"viva-continues-its-focus-on-multidisciplinary-education\",\"postDate\":1512165900,\"expiryDate\":null,\"enabled\":1,\"parentId\":null,\"fields\":{\"1\":\"<p>As the field of vascular medicine rapidly evolves, VIVA (Vascular InterVentional Advances) continues to be at the forefront of interactive, multispecialty education. Now in its 16th year, this annual conference offers attendees the opportunity to hear distinguished speakers in the vascular medicine field discuss the most relevant issues. VIVA\\u2019s hot topics for 2018 include complications management, critical limb ischemia, pharmacotherapy, a special session on disruptive technologies, and more.<\\/p>\\r\\n<p>As VIVA Physicians Board President Dr. John Kaufman notes, \\u201cIt\\u2019s difficult for a practitioner to sift through new information to understand what\\u2019s important. VIVA is structured to provide you with that analysis, that critical view of the data and information, in a compact way from multiple specialists.\\u201d VIVA\\u2019s faculty and attendees provide representation from interventional cardiology, interventional radiology, vascular and cardiothoracic surgery, and vascular medicine. The benefit of this is that \\u201cyou won\\u2019t get just the party line from one group of individuals,\\u201d Kaufman says. \\u201cYou\\u2019ll hear from everybody in a distilled manner&mdash;what\\u2019s important and what you need to know going forward.\\u201d<\\/p>\\r\\n<p>VIVA offers vascular medicine practitioners of all levels a chance to interact with speakers and attendees through a variety of educational formats. For fellows and physicians-in-training there are presentations on finding and succeeding in a first job, the importance of achieving an optimal work-life balance, and guidance on making contributions in the field.<\\/p>\\r\\n<p>Additionally, attendees can leverage the power of the Virtual VIVA app to interact with faculty, view live cases, and review presentations. VIVA uses innovative technology to bring \\u201cthe newest, latest, and greatest information to practitioners across the spectrum,\\u201d says Dr. Joshua Beckman, VIVA Physicians board member. \\u201cWe are agnostic to your specialty type, but we are particular to your specialty ability.\\u201d<\\/p>\\r\\n<p>VIVA will be held November 5-8, 2018, at the Wynn Las Vegas. Registration opens Spring 2018. Visit <a href=\\\"http:\\/\\/www.vivaphysicians.org\\/\\\">www.vivaphysicians.org<\\/a> for more information.<\\/p>\\r\\n<h3><strong>The VEINS at VIVA in Its 4<\\/strong><strong>th<\\/strong><strong> Year<\\/strong><\\/h3>\\r\\n<p>The VEINS (Venous Endovascular INterventional Strategies) at VIVA symposium has expanded to 2 full days in 2018 to provide more time to explore the treatment and challenges of venous thromboembolism diseases.<\\/p>\\r\\n<p>Pulmonary embolism treatment, controversies in VTE management, and breaking data on deep venous intervention will headline the course. Also of focus will be the growing success and importance of Pulmonary Embolism Response Teams (PERT), along with sessions on wound care and diagnosis and management strategies for superficial venous disease.<\\/p>\\r\\n<p>The VEINS at VIVA 18 will bring an in-depth look into the rapidly evolving field of venous disease medicine. Course directors Dr. Raghu Kolluri and Dr. John Kaufman will head up a multidisciplinary faculty as they present a comprehensive analysis of critical issues facing today\\u2019s vascular specialists.<\\/p>\\r\\n<p>The VEINS at VIVA will be held November 4-5, 2018, at the Wynn Las Vegas. Registration opens Spring 2018. Visit <a href=\\\"http:\\/\\/www.vivaphysicians.org\\/\\\">www.vivaphysicians.org<\\/a> for more information.<\\/p>\",\"2\":\"\"}}', '2018-02-09 01:11:53', '2018-02-09 01:11:53', '1ebb1a6e-139a-4e97-9323-554b8be2f7dc'),
 ('12', '2', '1', '1', 'en_us', '3', '', '{\"typeId\":null,\"authorId\":null,\"title\":\"Home\",\"slug\":\"homepage\",\"postDate\":1516819038,\"expiryDate\":null,\"enabled\":1,\"parentId\":null,\"fields\":{\"7\":\"\",\"6\":\"\",\"8\":\"\",\"9\":\"\",\"3\":\"\",\"4\":\"\",\"5\":\"\"}}', '2018-02-09 21:28:21', '2018-02-09 21:28:21', 'e69a23bd-5b10-4a0d-9731-bc378bed8bb5');



DROP TABLE IF EXISTS `craft_fieldgroups`;


--
-- Schema for table `craft_fieldgroups`
--
CREATE TABLE `craft_fieldgroups` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `name` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_fieldgroups_name_unq_idx` (`name`)
) ENGINE=InnoDB AUTO_INCREMENT=3 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

--
-- Data for table `craft_fieldgroups`
--

INSERT INTO `craft_fieldgroups` (`id`, `name`, `dateCreated`, `dateUpdated`, `uid`) VALUES
 ('1', 'Default', '2018-01-24 18:37:17', '2018-01-24 18:37:17', '9f993c08-327b-4967-8cd8-596f74d7abdd'),
 ('2', 'Homepage', '2018-02-09 17:48:15', '2018-02-09 17:48:15', '130e95f9-e41e-4191-94d4-08450f22bb2a');



DROP TABLE IF EXISTS `craft_fieldlayoutfields`;


--
-- Schema for table `craft_fieldlayoutfields`
--
CREATE TABLE `craft_fieldlayoutfields` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `layoutId` int(11) NOT NULL,
  `tabId` int(11) NOT NULL,
  `fieldId` int(11) NOT NULL,
  `required` tinyint(1) unsigned NOT NULL DEFAULT '0',
  `sortOrder` smallint(6) unsigned DEFAULT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_fieldlayoutfields_layoutId_fieldId_unq_idx` (`layoutId`,`fieldId`),
  KEY `craft_fieldlayoutfields_sortOrder_idx` (`sortOrder`),
  KEY `craft_fieldlayoutfields_tabId_fk` (`tabId`),
  KEY `craft_fieldlayoutfields_fieldId_fk` (`fieldId`)
) ENGINE=InnoDB AUTO_INCREMENT=23 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

--
-- Data for table `craft_fieldlayoutfields`
--

INSERT INTO `craft_fieldlayoutfields` (`id`, `layoutId`, `tabId`, `fieldId`, `required`, `sortOrder`, `dateCreated`, `dateUpdated`, `uid`) VALUES
 ('2', '5', '2', '1', '1', '1', '2018-01-24 18:37:18', '2018-01-24 18:37:18', '60e5ee2c-7fd9-4ffe-a3af-3efe9f35f09b'),
 ('3', '5', '2', '2', '0', '2', '2018-01-24 18:37:18', '2018-01-24 18:37:18', '34074d2a-e2b4-4dc0-a321-23c4422f141c'),
 ('11', '8', '4', '7', '0', '1', '2018-02-09 21:32:21', '2018-02-09 21:32:21', '15ae4049-9a65-4c57-bd55-5f4d9ac07020'),
 ('12', '8', '4', '6', '0', '2', '2018-02-09 21:32:21', '2018-02-09 21:32:21', '6d6f7ab8-51b5-4c73-8696-3fc8a223a5c5'),
 ('13', '8', '4', '8', '0', '3', '2018-02-09 21:32:21', '2018-02-09 21:32:21', '9f5fbf2c-5125-4baf-80e3-ab946761d03d'),
 ('14', '8', '4', '9', '0', '4', '2018-02-09 21:32:21', '2018-02-09 21:32:21', '6cb900eb-83e3-4cce-b024-e3377d58c5cc'),
 ('15', '8', '4', '3', '0', '5', '2018-02-09 21:32:21', '2018-02-09 21:32:21', '61cc6df7-fcc0-47ee-afe1-c433728c5f64'),
 ('16', '8', '4', '4', '0', '6', '2018-02-09 21:32:21', '2018-02-09 21:32:21', '674e6fd2-c447-4e13-86f4-78b85362748e'),
 ('17', '8', '4', '5', '0', '7', '2018-02-09 21:32:21', '2018-02-09 21:32:21', 'fec52429-22a9-473f-9b01-eae931331314'),
 ('18', '8', '4', '10', '0', '8', '2018-02-09 21:32:21', '2018-02-09 21:32:21', '879cdeac-d794-48de-8049-e0881abb5d69'),
 ('19', '8', '4', '11', '0', '9', '2018-02-09 21:32:21', '2018-02-09 21:32:21', '0ee8e822-422d-4db6-bf28-0211e3b74a54'),
 ('20', '8', '4', '12', '0', '10', '2018-02-09 21:32:21', '2018-02-09 21:32:21', 'ab8652c4-5802-47d1-96b2-a98768c2f99b'),
 ('21', '8', '4', '14', '0', '11', '2018-02-09 21:32:21', '2018-02-09 21:32:21', 'd0632275-1ee8-4688-9923-5f03ddac9f8f'),
 ('22', '8', '4', '13', '0', '12', '2018-02-09 21:32:21', '2018-02-09 21:32:21', '11d83745-09bc-48fb-8da2-8017b618afe0');



DROP TABLE IF EXISTS `craft_fieldlayouts`;


--
-- Schema for table `craft_fieldlayouts`
--
CREATE TABLE `craft_fieldlayouts` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `type` varchar(150) COLLATE utf8_unicode_ci NOT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  KEY `craft_fieldlayouts_type_idx` (`type`)
) ENGINE=InnoDB AUTO_INCREMENT=9 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

--
-- Data for table `craft_fieldlayouts`
--

INSERT INTO `craft_fieldlayouts` (`id`, `type`, `dateCreated`, `dateUpdated`, `uid`) VALUES
 ('1', 'Tag', '2018-01-24 18:37:17', '2018-01-24 18:37:17', 'f2e805d2-3191-4af1-8deb-aac69d05317f'),
 ('5', 'Entry', '2018-01-24 18:37:18', '2018-01-24 18:37:18', 'b0034b50-8ae2-4cd5-a4a3-03242ce7759c'),
 ('6', 'Asset', '2018-01-24 19:04:13', '2018-01-24 19:04:13', '40a250d5-231e-4fb7-911d-3cd3adb01766'),
 ('8', 'Entry', '2018-02-09 21:32:21', '2018-02-09 21:32:21', '74b2f6ab-5623-464f-840d-502054d3a644');



DROP TABLE IF EXISTS `craft_fieldlayouttabs`;


--
-- Schema for table `craft_fieldlayouttabs`
--
CREATE TABLE `craft_fieldlayouttabs` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `layoutId` int(11) NOT NULL,
  `name` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `sortOrder` smallint(6) unsigned DEFAULT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  KEY `craft_fieldlayouttabs_sortOrder_idx` (`sortOrder`),
  KEY `craft_fieldlayouttabs_layoutId_fk` (`layoutId`)
) ENGINE=InnoDB AUTO_INCREMENT=5 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

--
-- Data for table `craft_fieldlayouttabs`
--

INSERT INTO `craft_fieldlayouttabs` (`id`, `layoutId`, `name`, `sortOrder`, `dateCreated`, `dateUpdated`, `uid`) VALUES
 ('2', '5', 'Content', '1', '2018-01-24 18:37:18', '2018-01-24 18:37:18', 'c5b2770c-4ac3-44fd-b411-b64e95bb4966'),
 ('4', '8', 'Homepage', '1', '2018-02-09 21:32:21', '2018-02-09 21:32:21', '08369333-a1f4-45d5-83ef-b359ddc5eaef');



DROP TABLE IF EXISTS `craft_fields`;


--
-- Schema for table `craft_fields`
--
CREATE TABLE `craft_fields` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `groupId` int(11) DEFAULT NULL,
  `name` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `handle` varchar(58) COLLATE utf8_unicode_ci NOT NULL,
  `context` varchar(255) COLLATE utf8_unicode_ci NOT NULL DEFAULT 'global',
  `instructions` text COLLATE utf8_unicode_ci,
  `translatable` tinyint(1) unsigned NOT NULL DEFAULT '0',
  `type` varchar(150) COLLATE utf8_unicode_ci NOT NULL,
  `settings` text COLLATE utf8_unicode_ci,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_fields_handle_context_unq_idx` (`handle`,`context`),
  KEY `craft_fields_context_idx` (`context`),
  KEY `craft_fields_groupId_fk` (`groupId`)
) ENGINE=InnoDB AUTO_INCREMENT=15 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

--
-- Data for table `craft_fields`
--

INSERT INTO `craft_fields` (`id`, `groupId`, `name`, `handle`, `context`, `instructions`, `translatable`, `type`, `settings`, `dateCreated`, `dateUpdated`, `uid`) VALUES
 ('1', '1', 'Body', 'body', 'global', NULL, '1', 'RichText', '{\"configFile\":\"Standard.json\",\"columnType\":\"text\"}', '2018-01-24 18:37:18', '2018-01-24 18:37:18', '46272f68-8ae6-445c-906c-e8c1ff110b9f'),
 ('2', '1', 'Tags', 'tags', 'global', NULL, '0', 'Tags', '{\"source\":\"taggroup:1\"}', '2018-01-24 18:37:18', '2018-01-24 18:37:18', 'ba6eaf6d-015c-44ee-9fda-5bdfbb6760ec'),
 ('3', '2', 'Veins Dates', 'veinsDates', 'global', 'Red text above veins header text, meant to present conference dates ', '0', 'PlainText', '{\"placeholder\":\"\",\"maxLength\":\"100\",\"multiline\":\"\",\"initialRows\":\"4\"}', '2018-02-09 17:50:23', '2018-02-09 17:50:23', '35945c58-7a88-47b5-bb4e-886c30d1a7e1'),
 ('4', '2', 'Veins Header', 'veinsHeader', 'global', 'Large banner text for veins conference', '0', 'PlainText', '{\"placeholder\":\"\",\"maxLength\":\"50\",\"multiline\":\"\",\"initialRows\":\"4\"}', '2018-02-09 17:51:38', '2018-02-09 17:51:38', 'ce048140-2444-4fb6-8358-058b9fae167b'),
 ('5', '2', 'Veins Subheader', 'veinsSubheader', 'global', 'Explanatory text underneath veins header', '0', 'PlainText', '{\"placeholder\":\"\",\"maxLength\":\"\",\"multiline\":\"\",\"initialRows\":\"4\"}', '2018-02-09 17:52:01', '2018-02-09 17:52:01', 'dd3ecf7a-2757-4f97-b41b-6c21aa74930f'),
 ('6', '2', 'Body Title 1', 'bodyTitle1', 'global', 'First body title underneath banner image', '0', 'PlainText', '{\"placeholder\":\"\",\"maxLength\":\"\",\"multiline\":\"\",\"initialRows\":\"4\"}', '2018-02-09 17:54:15', '2018-02-09 17:54:15', '0fa1eec6-ab93-4de4-8f3f-8dada44cecfc'),
 ('7', '2', 'Body Text 1', 'bodyText1', 'global', 'Body copy underneath body title 1', '0', 'PlainText', '{\"placeholder\":\"\",\"maxLength\":\"\",\"multiline\":\"\",\"initialRows\":\"4\"}', '2018-02-09 17:54:33', '2018-02-09 17:54:33', 'a0e02a1a-67ca-463b-9aa9-1a1c8ffb8d26'),
 ('8', '2', 'Testimonial Quote One', 'testimonialQuoteOne', 'global', 'First testimonial quote in testimonial slider', '0', 'PlainText', '{\"placeholder\":\"\",\"maxLength\":\"\",\"multiline\":\"\",\"initialRows\":\"4\"}', '2018-02-09 19:27:18', '2018-02-09 19:27:53', '4869be30-5c03-434b-98ee-e05259718932'),
 ('9', '2', 'Testimonial Source One', 'testimonialSourceOne', 'global', 'Testimonial reference under Testimonial Body One', '0', 'PlainText', '{\"placeholder\":\"\",\"maxLength\":\"\",\"multiline\":\"\",\"initialRows\":\"4\"}', '2018-02-09 19:28:56', '2018-02-09 19:28:56', '45d79582-c126-41cf-b1d9-da8221a6e490'),
 ('10', '2', 'Viva 2018 Text', 'viva2018Text', 'global', 'Text in purple block below \"Viva 2018\"', '0', 'PlainText', '{\"placeholder\":\"\",\"maxLength\":\"\",\"multiline\":\"\",\"initialRows\":\"4\"}', '2018-02-09 21:17:35', '2018-02-09 21:17:35', '71201732-6e6a-46e6-82a2-0f731cb79035'),
 ('11', '2', 'Veins at Viva text', 'veinsAtVivaText', 'global', 'Text in purple block below \"Veins at Viva\"', '0', 'PlainText', '{\"placeholder\":\"\",\"maxLength\":\"\",\"multiline\":\"\",\"initialRows\":\"4\"}', '2018-02-09 21:18:41', '2018-02-09 21:18:41', '30ee2723-6865-422b-bb62-e2bdfa99465a'),
 ('12', '2', 'Industry', 'industry', 'global', 'Text in purple block below \"Industry\"', '0', 'PlainText', '{\"placeholder\":\"\",\"maxLength\":\"\",\"multiline\":\"\",\"initialRows\":\"4\"}', '2018-02-09 21:19:10', '2018-02-09 21:19:10', '4933297d-6ccf-4f9f-af26-15ed7ac3d1b5'),
 ('13', '2', 'Virtual Viva Header', 'virtualVivaHeader', 'global', 'Header text for virtual viva block', '0', 'PlainText', '{\"placeholder\":\"\",\"maxLength\":\"\",\"multiline\":\"\",\"initialRows\":\"4\"}', '2018-02-09 21:20:08', '2018-02-09 21:20:08', '4dfdc187-9edd-4735-8690-8b329cc55d97'),
 ('14', '2', 'Virtual Viva Body', 'virtualVivaBody', 'global', 'Body text for virtual viva block', '0', 'PlainText', '{\"placeholder\":\"\",\"maxLength\":\"\",\"multiline\":\"\",\"initialRows\":\"4\"}', '2018-02-09 21:20:24', '2018-02-09 21:20:24', '24dbe389-0fe2-4e3b-ac3e-a4ad0dc92187');



DROP TABLE IF EXISTS `craft_globalsets`;


--
-- Schema for table `craft_globalsets`
--
CREATE TABLE `craft_globalsets` (
  `id` int(11) NOT NULL,
  `name` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `handle` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `fieldLayoutId` int(10) DEFAULT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_globalsets_name_unq_idx` (`name`),
  UNIQUE KEY `craft_globalsets_handle_unq_idx` (`handle`),
  KEY `craft_globalsets_fieldLayoutId_fk` (`fieldLayoutId`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_info`;


--
-- Schema for table `craft_info`
--
CREATE TABLE `craft_info` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `version` varchar(50) COLLATE utf8_unicode_ci NOT NULL,
  `schemaVersion` varchar(15) COLLATE utf8_unicode_ci NOT NULL,
  `edition` tinyint(1) unsigned NOT NULL DEFAULT '0',
  `siteName` varchar(100) COLLATE utf8_unicode_ci NOT NULL,
  `siteUrl` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `timezone` varchar(30) COLLATE utf8_unicode_ci DEFAULT NULL,
  `on` tinyint(1) unsigned NOT NULL DEFAULT '0',
  `maintenance` tinyint(1) unsigned NOT NULL DEFAULT '0',
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=2 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

--
-- Data for table `craft_info`
--

INSERT INTO `craft_info` (`id`, `version`, `schemaVersion`, `edition`, `siteName`, `siteUrl`, `timezone`, `on`, `maintenance`, `dateCreated`, `dateUpdated`, `uid`) VALUES
 ('1', '2.6.3005', '2.6.13', '0', 'VIVA Physicians', 'http://ec2-54-165-224-216.compute-1.amazonaws.com', 'UTC', '1', '1', '2018-01-24 18:37:16', '2018-02-09 21:42:02', '8b8f7650-2989-4464-a956-ad43aa1cec88');



DROP TABLE IF EXISTS `craft_locales`;


--
-- Schema for table `craft_locales`
--
CREATE TABLE `craft_locales` (
  `locale` char(12) COLLATE utf8_unicode_ci NOT NULL,
  `sortOrder` smallint(6) unsigned DEFAULT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`locale`),
  KEY `craft_locales_sortOrder_idx` (`sortOrder`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

--
-- Data for table `craft_locales`
--

INSERT INTO `craft_locales` (`locale`, `sortOrder`, `dateCreated`, `dateUpdated`, `uid`) VALUES
 ('en_us', '1', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '6f397b72-2f44-4087-8e1b-83d3f26a5650');



DROP TABLE IF EXISTS `craft_matrixblocks`;


--
-- Schema for table `craft_matrixblocks`
--
CREATE TABLE `craft_matrixblocks` (
  `id` int(11) NOT NULL,
  `ownerId` int(11) NOT NULL,
  `fieldId` int(11) NOT NULL,
  `typeId` int(11) DEFAULT NULL,
  `sortOrder` smallint(6) unsigned DEFAULT NULL,
  `ownerLocale` char(12) COLLATE utf8_unicode_ci DEFAULT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  KEY `craft_matrixblocks_ownerId_idx` (`ownerId`),
  KEY `craft_matrixblocks_fieldId_idx` (`fieldId`),
  KEY `craft_matrixblocks_typeId_idx` (`typeId`),
  KEY `craft_matrixblocks_sortOrder_idx` (`sortOrder`),
  KEY `craft_matrixblocks_ownerLocale_fk` (`ownerLocale`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_matrixblocktypes`;


--
-- Schema for table `craft_matrixblocktypes`
--
CREATE TABLE `craft_matrixblocktypes` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `fieldId` int(11) NOT NULL,
  `fieldLayoutId` int(11) DEFAULT NULL,
  `name` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `handle` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `sortOrder` smallint(6) unsigned DEFAULT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_matrixblocktypes_name_fieldId_unq_idx` (`name`,`fieldId`),
  UNIQUE KEY `craft_matrixblocktypes_handle_fieldId_unq_idx` (`handle`,`fieldId`),
  KEY `craft_matrixblocktypes_fieldId_fk` (`fieldId`),
  KEY `craft_matrixblocktypes_fieldLayoutId_fk` (`fieldLayoutId`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_migrations`;


--
-- Schema for table `craft_migrations`
--
CREATE TABLE `craft_migrations` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `pluginId` int(11) DEFAULT NULL,
  `version` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `applyTime` datetime NOT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_migrations_version_unq_idx` (`version`),
  KEY `craft_migrations_pluginId_fk` (`pluginId`)
) ENGINE=InnoDB AUTO_INCREMENT=43 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

--
-- Data for table `craft_migrations`
--

INSERT INTO `craft_migrations` (`id`, `pluginId`, `version`, `applyTime`, `dateCreated`, `dateUpdated`, `uid`) VALUES
 ('1', NULL, 'm000000_000000_base', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', 'f9e607d9-450a-403f-b424-023ea5c51a7e'),
 ('2', NULL, 'm140730_000001_add_filename_and_format_to_transformindex', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '14ad9262-b98d-4c8c-8dbf-1d9c0d6b8e63'),
 ('3', NULL, 'm140815_000001_add_format_to_transforms', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', 'ec01f34d-db03-4c35-a8b6-200c303e1a1a'),
 ('4', NULL, 'm140822_000001_allow_more_than_128_items_per_field', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '767fc8ef-f1df-4374-9d2d-80c7acf6a339'),
 ('5', NULL, 'm140829_000001_single_title_formats', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', 'f941cd1a-629a-49e8-aadd-9576548ce9e4'),
 ('6', NULL, 'm140831_000001_extended_cache_keys', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', 'e21ae441-8601-46d8-bec0-fa9755e2e61a'),
 ('7', NULL, 'm140922_000001_delete_orphaned_matrix_blocks', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '5842a2a1-e619-409a-b538-3960d6f40144'),
 ('8', NULL, 'm141008_000001_elements_index_tune', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', 'bef468cd-5c55-4c4d-8c4d-8f40d5122ffa'),
 ('9', NULL, 'm141009_000001_assets_source_handle', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '7e735b2a-ebcf-4b51-a9c3-7640ab9c30e4'),
 ('10', NULL, 'm141024_000001_field_layout_tabs', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', 'c5998169-505f-4a1b-bbb7-8fd1421112b5'),
 ('11', NULL, 'm141030_000000_plugin_schema_versions', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '6bd7bd45-f688-479f-9caf-5848e2f11ea8'),
 ('12', NULL, 'm141030_000001_drop_structure_move_permission', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '95d12ccc-0e56-4c02-abc0-c0bfbd468750'),
 ('13', NULL, 'm141103_000001_tag_titles', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '098f09e8-6753-43cb-aaab-57e0e1c68f09'),
 ('14', NULL, 'm141109_000001_user_status_shuffle', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '45532165-107b-447b-bcd1-c1301badd57c'),
 ('15', NULL, 'm141126_000001_user_week_start_day', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '4a3a01ec-bf65-48ff-8c93-f165cd238ad6'),
 ('16', NULL, 'm150210_000001_adjust_user_photo_size', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '89e7cfa4-2a87-41f4-bc45-4a7c624ccd60'),
 ('17', NULL, 'm150724_000001_adjust_quality_settings', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '8317d27e-0ba1-4287-9f7d-f467f666d258'),
 ('18', NULL, 'm150827_000000_element_index_settings', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '7202644c-ebad-4a2a-a526-8239600fb9d1'),
 ('19', NULL, 'm150918_000001_add_colspan_to_widgets', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '464e83a0-0a6a-433f-987b-59e5cae02258'),
 ('20', NULL, 'm151007_000000_clear_asset_caches', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '802a395c-3cee-4b7b-a9b3-303f76e93a44'),
 ('21', NULL, 'm151109_000000_text_url_formats', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', 'a6193e81-cd80-4051-bf3c-f7a880f72874'),
 ('22', NULL, 'm151110_000000_move_logo', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', 'e8ef31ab-c951-4da7-a1fd-1327d0c5ac7c'),
 ('23', NULL, 'm151117_000000_adjust_image_widthheight', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2e682dbc-e5ed-491a-b29b-03af694f2f37'),
 ('24', NULL, 'm151127_000000_clear_license_key_status', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', 'acab6f55-ef3a-41f5-b68a-90a2031bbdd4'),
 ('25', NULL, 'm151127_000000_plugin_license_keys', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', 'c33e4caf-700e-4d28-89a1-1ea44ac94b32'),
 ('26', NULL, 'm151130_000000_update_pt_widget_feeds', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '63f0b9c7-e269-472e-8854-6e2c6fb4530a'),
 ('27', NULL, 'm160114_000000_asset_sources_public_url_default_true', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', 'c71699fe-e561-4039-97ed-d9bf3d641a33'),
 ('28', NULL, 'm160223_000000_sortorder_to_smallint', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '66089fdf-c738-4d63-b07a-db37b57df2f3'),
 ('29', NULL, 'm160229_000000_set_default_entry_statuses', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '6cb2d3bd-e277-499f-b440-bc2b904819b4'),
 ('30', NULL, 'm160304_000000_client_permissions', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', 'a1b2a677-d5a6-499e-8403-943a9ecda96a'),
 ('31', NULL, 'm160322_000000_asset_filesize', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '449d9c8e-71e4-43ee-9917-03041e966d0f'),
 ('32', NULL, 'm160503_000000_orphaned_fieldlayouts', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', 'd6a3e1c9-8863-4a5f-96e4-3b5fc2391bbd'),
 ('33', NULL, 'm160510_000000_tasksettings', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '71cdbebc-552e-4846-9146-98b787417fcf'),
 ('34', NULL, 'm160829_000000_pending_user_content_cleanup', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', 'b1564e50-ec25-411d-a8ee-ea5e55aec4af'),
 ('35', NULL, 'm160830_000000_asset_index_uri_increase', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', 'a4c84d71-b95d-47f6-a147-76a8303c81d7'),
 ('36', NULL, 'm160919_000000_usergroup_handle_title_unique', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', 'b2d8ad33-2df5-49db-ba11-f912b690e55c'),
 ('37', NULL, 'm161108_000000_new_version_format', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', 'dd5630f7-a8d8-4a23-9fae-20dc140339ad'),
 ('38', NULL, 'm161109_000000_index_shuffle', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '8ee0b8ba-c043-4fa9-afb8-23c8a6ea7b33'),
 ('39', NULL, 'm170612_000000_route_index_shuffle', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '779d098e-e8fa-4abe-9777-24668b0d14ec'),
 ('40', NULL, 'm171107_000000_assign_group_permissions', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '333c12b9-89ca-4f9f-99d9-0627b240358d'),
 ('41', NULL, 'm171117_000001_templatecache_index_tune', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', 'a8a8c582-8681-44c1-a713-2b15daed8fa0'),
 ('42', NULL, 'm171204_000001_templatecache_index_tune_deux', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '2018-01-24 18:37:16', '7731cca0-62e0-4772-8170-6e47559b2b15');



DROP TABLE IF EXISTS `craft_plugins`;


--
-- Schema for table `craft_plugins`
--
CREATE TABLE `craft_plugins` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `class` varchar(150) COLLATE utf8_unicode_ci NOT NULL,
  `version` varchar(15) COLLATE utf8_unicode_ci NOT NULL,
  `schemaVersion` varchar(15) COLLATE utf8_unicode_ci DEFAULT NULL,
  `licenseKey` char(24) COLLATE utf8_unicode_ci DEFAULT NULL,
  `licenseKeyStatus` enum('valid','invalid','mismatched','unknown') COLLATE utf8_unicode_ci NOT NULL DEFAULT 'unknown',
  `enabled` tinyint(1) unsigned NOT NULL DEFAULT '0',
  `settings` text COLLATE utf8_unicode_ci,
  `installDate` datetime NOT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_rackspaceaccess`;


--
-- Schema for table `craft_rackspaceaccess`
--
CREATE TABLE `craft_rackspaceaccess` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `connectionKey` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `token` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `storageUrl` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `cdnUrl` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_rackspaceaccess_connectionKey_unq_idx` (`connectionKey`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_relations`;


--
-- Schema for table `craft_relations`
--
CREATE TABLE `craft_relations` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `fieldId` int(11) NOT NULL,
  `sourceId` int(11) NOT NULL,
  `sourceLocale` char(12) COLLATE utf8_unicode_ci DEFAULT NULL,
  `targetId` int(11) NOT NULL,
  `sortOrder` smallint(6) DEFAULT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_relations_fieldId_sourceId_sourceLocale_targetId_unq_idx` (`fieldId`,`sourceId`,`sourceLocale`,`targetId`),
  KEY `craft_relations_sourceId_fk` (`sourceId`),
  KEY `craft_relations_sourceLocale_fk` (`sourceLocale`),
  KEY `craft_relations_targetId_fk` (`targetId`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_routes`;


--
-- Schema for table `craft_routes`
--
CREATE TABLE `craft_routes` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `locale` char(12) COLLATE utf8_unicode_ci DEFAULT NULL,
  `urlParts` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `urlPattern` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `template` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `sortOrder` smallint(6) unsigned DEFAULT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  KEY `craft_routes_locale_idx` (`locale`),
  KEY `craft_routes_urlPattern_idx` (`urlPattern`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_searchindex`;


--
-- Schema for table `craft_searchindex`
--
CREATE TABLE `craft_searchindex` (
  `elementId` int(11) NOT NULL,
  `attribute` varchar(25) COLLATE utf8_unicode_ci NOT NULL,
  `fieldId` int(11) NOT NULL,
  `locale` char(12) COLLATE utf8_unicode_ci NOT NULL,
  `keywords` text COLLATE utf8_unicode_ci NOT NULL,
  PRIMARY KEY (`elementId`,`attribute`,`fieldId`,`locale`),
  FULLTEXT KEY `craft_searchindex_keywords_idx` (`keywords`)
) ENGINE=MyISAM DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

--
-- Data for table `craft_searchindex`
--

INSERT INTO `craft_searchindex` (`elementId`, `attribute`, `fieldId`, `locale`, `keywords`) VALUES
 ('1', 'username', '0', 'en_us', ' jasonroot '),
 ('1', 'firstname', '0', 'en_us', ''),
 ('1', 'lastname', '0', 'en_us', ''),
 ('1', 'fullname', '0', 'en_us', ''),
 ('1', 'email', '0', 'en_us', ' hello jasonroot com '),
 ('1', 'slug', '0', 'en_us', ''),
 ('2', 'slug', '0', 'en_us', ' homepage '),
 ('2', 'title', '0', 'en_us', ' home '),
 ('2', 'field', '1', 'en_us', ' it s true this site doesn t have a whole lot of content yet but don t worry our web developers have just installed the cms and they re setting things up for the content editors this very moment soon ec2 54 165 224 216 compute 1 amazonaws com will be an oasis of fresh perspectives sharp analyses and astute opinions that will keep you coming back again and again '),
 ('91', 'field', '1', 'en_us', ' michael r jaff do and kenneth rosenfield md vascular medicine massachusetts general hospital boston we know a lot about pulmonary emboli pe we know that that though the risk for pe increases with each decade over the age of 40 1 there is no adult patient population that is immune to the potentially devastating manifestations of pe from a recent review of the risk of venous thromboemboli during or following prolonged air travel we know that patients with one or more risk factors for pe should wear graduated compression stockings avoid dehydration and be considered for pharmacoprophylaxis 2 from the guidelines of our medical societies we have recommendations for treatment of pe in many scenarios for example the american college of chest physicians recently updated its guidelines to recommend systemic thrombolytic therapy over catheter based therapy for patients with only pe and hypotension 3 and the european society of cardiology recommends primary reperfusion for the treatment of pe patients at high and intermediate high risk 4 recent data support the use of systemic thrombolytic therapy for pe 5 we ve learned so much that today there is little debate about the management of hemodynamically stable minimally symptomatic pe patients for these patients the only controversy is which anticoagulant is most appropriate so yes we know a lot unfortunately there s a lot we still need to learn for starters we don t know the best treatment for submassive or massive pe the options for treating these patients are almost as numerous as the opinions of the specialists who contribute to managing these conditions we know about the challenges bleeding risk the often devastating impact of pe on long term survival the costs associated with advanced pe therapies and that our institutions many of them already stretched thin struggle to identify patients who might have pe and then to perform rapid and definitive tests and treatments for those who present during off hours from our successes with acute myocardial infarction stemi and stroke teams we know that the key to successfully reducing morbidity and mortality from pe likely lies in learning how to improve our systems so that we rapidly deploy the right team of providers at the right time pulmonary embolus response teams pert have been described as a means to achieve that goal 6 and data regarding patient management within an institution offering care through such teams has been published 7 however as skeptics have suggested we don t know enough about the costs of running pert programs we don t yet know if risks ensue when such programs are dominated by specialists who perform pe interventions despite the demonstrated benefits of acute stroke and stemi teams we don t yet have enough data to confirm the value of pert programs again there s a lot we don t know and therefore there s a lot for us to debate if you manage pe patients please join us at the massachusetts general fireman vascular cme symposium on pulmonary embolism on june 28 29 2016 there you will see world renowned experts coming come together to examine what we know and what we don t know and to debate the knowledge gaps and how best to fill them yes there s a lot we don t know about this all too common and potentially deadly condition let s change that visit www pertconsortium org references raskob ge angchaisuksiri p blanco an et al thrombosis a major contributor to global disease burden arterioscler thromb vasc biol 2014 34 2363 71 philbrick jt shumate r siadaty ms becker dm air travel and venous thromboembolism a systematic review j gen intern med 2007 22 107 114 kearon c aki ea ornelas j et al antithrombotic therapy for vte disease chest guideline and expert panel report chest 2016 149 315 52 konstantinides sv torbick a agnelli g et al 2014 esc guidelines on the diagnosis and management of acute pulmonary embolism 2014 33 3033 80 chatterjee s chakraborty a weinberg i et al thrombolysis for pulmonary embolism and risk of all cause mortality major bleeding and intracranial hemorrhage a meta analysis jama 2014 311 2414 21 kabrhel c jaff mr channick r baker j rosenfield k a multidisciplinary pulmonary embolism response team chest 2013 144 1738 9 kabhrel c rosovsky r channick r et al a multispecialty pulmonary embolism response team pert initial 30 month experience with a novel approach to delivery of care to patients with sub massive and massive pe chest 2016 march 19 epub ahead of print '),
 ('92', 'title', '0', 'en_us', ' edoxaban in venous thromboembolism clinical considerations '),
 ('92', 'field', '2', 'en_us', ''),
 ('92', 'slug', '0', 'en_us', ' edoxaban in venous thromboembolism clinical considerations '),
 ('92', 'field', '1', 'en_us', ' edoxaban marketed as savaysa daiichi sankyo tokyo an oral once daily factor xa inhibitor was approved by the fda on january 8 2015 for the prevention of stroke and systemic embolism in non valvular atrial fibrillation and for the treatment of venous thromboembolism vte in a press release issued by the fda the u s food and drug administration outlined a few reservations regarding the use of edoxaban in non valvular atrial fibrillation patients with creatinine clearance greater than 95 ml min had an increased rate of ischemic stroke with edoxaban as compared to warfarin such data does not exist regarding vte as part of its label edoxaban carries a boxed warning stating that edoxaban should not be used in non valvular atrial fibrillation patients with creatinine clearance greater than 95 ml min for the prevention of stroke for the treatment of vte edoxaban is only approved after a parenteral agent has been administered for 5 10 days the approval for the use of edoxaban in patients with non valvular atrial fibrillation is based on the engage af timi 48 study of 21 105 participants published in the new england journal of medicine in november 2013 this trial compared two doses of edoxaban to warfarin and revealed that the higher dose of edoxaban was non inferior to warfarin in the prevention of stroke and systemic embolism 1 18% and 1 5% respectively edoxaban demonstrated significantly less major bleeding and lower rates of intracranial hemorrhage compared to warfarin however there was a significant increase in gastrointestinal bleeding events with edoxaban versus warfarin the recommended dose of edoxaban for non valvular atrial fibrillation is 60 mg once daily creatinine clearance should be assessed before initiating therapy with edoxaban in patients with creatinine clearance between 15 ml min and 50 ml min the dose should be reduced to 30 mg daily it is important to note that edoxaban has not been studied in patients with mechanical heart valves or moderate or severe mitral stenosis and therefore it is not recommended in these patients as with any anticoagulant the premature discontinuation of edoxaban in the absence of alternative anticoagulation can increase the risk of ischemic events the approval for use in venous thromboembolism patients was based on the hokusai venous thromboembolism study published in the new england journal of medicine in october 2013 this study randomized 8 292 patients with dvt or pe to receive warfarin or edoxaban edoxaban was non inferior to warfarin in reducing the rates of recurrent vte 3 2% versus 3 5% respectively edoxaban was also associated with a significant decrease in the primary safety outcome of first or clinically relevant nonmajor bleeding compared to warfarin 8 5% vs 10 3% respectively p=0 004 for patients with normal renal function the recommended dose of edoxaban is 60 mg once daily following 5 10 days of a parenteral anticoagulant for patients with a creatinine clearance between 30 ml min and 50 ml min who weigh less than or equal to 60 kg or who are on concomitant p glycoprotein inhibitors the recommended dose of edoxaban is 30 mg once daily following a parenteral anticoagulant two important points were noted as part of the hokusai vte study that may set edoxaban apart from other new oral anticoagulants use of a parenteral agent because the hokusai vte trial included a run in phase with a parenteral agent unfractionated heparin or enoxaparin edoxaban is not approved without the use of a parenteral agent for the first 5 10 days this is in contrast to both rivaroxaban and apixaban two other oral xa inhibitors use in severe pulmonary embolism while rivaroxaban apixaban and dabigatran have been poorly studied in the setting of high risk pulmonary embolism there is some data to suggest that edoxaban is effective in this subset of patients rv dysfunction was found in over 34% in both the edoxaban and warfarin groups the authors speculated that the run in with a parenteral agent encouraged clinicians to enroll patients with severe vte edoxaban more frequently than in the other novel oral anticoagulant studiesless clinically relevant bleeding than warfarin there was a signal that showed superiority for clinically relevant bleeding major and minor this signal did not exist for the analysis examining major bleeding alone a small phase i trialpublished in january 2015 in circulation showed that bleeding measures could be reversed by administration of 4 factor prothrombin complex concentrate 4f pcc in patients who received edoxaban a meta analysis showed that novel oral anticoagulants in general are associated with less bleeding than warfarin including less intra cranial bleeding this meta analysis did not comment about edoxaban in particular in a phase i study published in the new england journal of medicine in nov 2014 per977 perosphere a small synthetic water soluble cationic molecule designed to bind specifically to unfractionated heparin and low molecular weight heparin has shown promise as a reversal agent and is being investigated in ongoing phase ii trials '),
 ('91', 'title', '0', 'en_us', ' there is a lot more to know about managing pulmonary emboli '),
 ('91', 'slug', '0', 'en_us', ' there is a lot more to know about managing pulmonary emboli '),
 ('91', 'field', '2', 'en_us', ''),
 ('90', 'title', '0', 'en_us', ' viva continues its focus on multidisciplinary education '),
 ('90', 'slug', '0', 'en_us', ' viva continues its focus on multidisciplinary education '),
 ('90', 'field', '2', 'en_us', ''),
 ('90', 'field', '1', 'en_us', ' as the field of vascular medicine rapidly evolves viva vascular interventional advances continues to be at the forefront of interactive multispecialty education now in its 16th year this annual conference offers attendees the opportunity to hear distinguished speakers in the vascular medicine field discuss the most relevant issues viva s hot topics for 2018 include complications management critical limb ischemia pharmacotherapy a special session on disruptive technologies and more as viva physicians board president dr john kaufman notes it s difficult for a practitioner to sift through new information to understand what s important viva is structured to provide you with that analysis that critical view of the data and information in a compact way from multiple specialists viva s faculty and attendees provide representation from interventional cardiology interventional radiology vascular and cardiothoracic surgery and vascular medicine the benefit of this is that you won t get just the party line from one group of individuals kaufman says you ll hear from everybody in a distilled manner what s important and what you need to know going forward viva offers vascular medicine practitioners of all levels a chance to interact with speakers and attendees through a variety of educational formats for fellows and physicians in training there are presentations on finding and succeeding in a first job the importance of achieving an optimal work life balance and guidance on making contributions in the field additionally attendees can leverage the power of the virtual viva app to interact with faculty view live cases and review presentations viva uses innovative technology to bring the newest latest and greatest information to practitioners across the spectrum says dr joshua beckman viva physicians board member we are agnostic to your specialty type but we are particular to your specialty ability viva will be held november 5 8 2018 at the wynn las vegas registration opens spring 2018 visit www vivaphysicians org for more information the veins at viva in its 4th year the veins venous endovascular interventional strategies at viva symposium has expanded to 2 full days in 2018 to provide more time to explore the treatment and challenges of venous thromboembolism diseases pulmonary embolism treatment controversies in vte management and breaking data on deep venous intervention will headline the course also of focus will be the growing success and importance of pulmonary embolism response teams pert along with sessions on wound care and diagnosis and management strategies for superficial venous disease the veins at viva 18 will bring an in depth look into the rapidly evolving field of venous disease medicine course directors dr raghu kolluri and dr john kaufman will head up a multidisciplinary faculty as they present a comprehensive analysis of critical issues facing today s vascular specialists the veins at viva will be held november 4 5 2018 at the wynn las vegas registration opens spring 2018 visit www vivaphysicians org for more information '),
 ('2', 'field', '7', 'en_us', ''),
 ('2', 'field', '6', 'en_us', ''),
 ('2', 'field', '8', 'en_us', ''),
 ('2', 'field', '9', 'en_us', ''),
 ('2', 'field', '3', 'en_us', ''),
 ('2', 'field', '4', 'en_us', ''),
 ('2', 'field', '5', 'en_us', '');



DROP TABLE IF EXISTS `craft_sections`;


--
-- Schema for table `craft_sections`
--
CREATE TABLE `craft_sections` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `structureId` int(11) DEFAULT NULL,
  `name` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `handle` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `type` enum('single','channel','structure') COLLATE utf8_unicode_ci NOT NULL DEFAULT 'channel',
  `hasUrls` tinyint(1) unsigned NOT NULL DEFAULT '1',
  `template` varchar(500) COLLATE utf8_unicode_ci DEFAULT NULL,
  `enableVersioning` tinyint(1) unsigned NOT NULL DEFAULT '0',
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_sections_name_unq_idx` (`name`),
  UNIQUE KEY `craft_sections_handle_unq_idx` (`handle`),
  KEY `craft_sections_structureId_fk` (`structureId`)
) ENGINE=InnoDB AUTO_INCREMENT=3 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

--
-- Data for table `craft_sections`
--

INSERT INTO `craft_sections` (`id`, `structureId`, `name`, `handle`, `type`, `hasUrls`, `template`, `enableVersioning`, `dateCreated`, `dateUpdated`, `uid`) VALUES
 ('1', NULL, 'Homepage', 'homepage', 'single', '1', 'index', '1', '2018-01-24 18:37:18', '2018-01-24 18:37:18', '688f20c3-8d8e-4976-9923-4a27ca118ee5'),
 ('2', NULL, 'News', 'news', 'channel', '1', 'news/_entry', '1', '2018-01-24 18:37:18', '2018-01-24 18:37:18', '1a80b9ee-a4fc-497c-971f-a1f4e2f0ea95');



DROP TABLE IF EXISTS `craft_sections_i18n`;


--
-- Schema for table `craft_sections_i18n`
--
CREATE TABLE `craft_sections_i18n` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `sectionId` int(11) NOT NULL,
  `locale` char(12) COLLATE utf8_unicode_ci NOT NULL,
  `enabledByDefault` tinyint(1) unsigned NOT NULL DEFAULT '1',
  `urlFormat` text COLLATE utf8_unicode_ci,
  `nestedUrlFormat` text COLLATE utf8_unicode_ci,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_sections_i18n_sectionId_locale_unq_idx` (`sectionId`,`locale`),
  KEY `craft_sections_i18n_locale_fk` (`locale`)
) ENGINE=InnoDB AUTO_INCREMENT=3 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

--
-- Data for table `craft_sections_i18n`
--

INSERT INTO `craft_sections_i18n` (`id`, `sectionId`, `locale`, `enabledByDefault`, `urlFormat`, `nestedUrlFormat`, `dateCreated`, `dateUpdated`, `uid`) VALUES
 ('1', '1', 'en_us', '1', '__home__', NULL, '2018-01-24 18:37:18', '2018-01-24 18:37:18', '7e5fee1f-fa5d-4f86-8a2e-edbe088df043'),
 ('2', '2', 'en_us', '1', 'news/{postDate.year}/{slug}', NULL, '2018-01-24 18:37:18', '2018-01-24 18:37:18', '76d08f80-4d29-4ccb-82f8-d984870ef3b0');



DROP TABLE IF EXISTS `craft_sessions`;


--
-- Schema for table `craft_sessions`
--
CREATE TABLE `craft_sessions` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `userId` int(11) NOT NULL,
  `token` char(100) COLLATE utf8_unicode_ci NOT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  KEY `craft_sessions_uid_idx` (`uid`),
  KEY `craft_sessions_token_idx` (`token`),
  KEY `craft_sessions_dateUpdated_idx` (`dateUpdated`),
  KEY `craft_sessions_userId_fk` (`userId`)
) ENGINE=InnoDB AUTO_INCREMENT=19 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_shunnedmessages`;


--
-- Schema for table `craft_shunnedmessages`
--
CREATE TABLE `craft_shunnedmessages` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `userId` int(11) NOT NULL,
  `message` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `expiryDate` datetime DEFAULT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_shunnedmessages_userId_message_unq_idx` (`userId`,`message`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_structureelements`;


--
-- Schema for table `craft_structureelements`
--
CREATE TABLE `craft_structureelements` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `structureId` int(11) NOT NULL,
  `elementId` int(11) DEFAULT NULL,
  `root` int(11) unsigned DEFAULT NULL,
  `lft` int(11) unsigned NOT NULL,
  `rgt` int(11) unsigned NOT NULL,
  `level` smallint(6) unsigned NOT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_structureelements_structureId_elementId_unq_idx` (`structureId`,`elementId`),
  KEY `craft_structureelements_root_idx` (`root`),
  KEY `craft_structureelements_lft_idx` (`lft`),
  KEY `craft_structureelements_rgt_idx` (`rgt`),
  KEY `craft_structureelements_level_idx` (`level`),
  KEY `craft_structureelements_elementId_fk` (`elementId`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_structures`;


--
-- Schema for table `craft_structures`
--
CREATE TABLE `craft_structures` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `maxLevels` smallint(6) unsigned DEFAULT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_systemsettings`;


--
-- Schema for table `craft_systemsettings`
--
CREATE TABLE `craft_systemsettings` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `category` varchar(15) COLLATE utf8_unicode_ci NOT NULL,
  `settings` text COLLATE utf8_unicode_ci,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_systemsettings_category_unq_idx` (`category`)
) ENGINE=InnoDB AUTO_INCREMENT=2 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

--
-- Data for table `craft_systemsettings`
--

INSERT INTO `craft_systemsettings` (`id`, `category`, `settings`, `dateCreated`, `dateUpdated`, `uid`) VALUES
 ('1', 'email', '{\"protocol\":\"php\",\"emailAddress\":\"hello@jasonroot.com\",\"senderName\":\"VIVA Physicians\"}', '2018-01-24 18:37:17', '2018-01-24 18:37:17', '6a3856c0-e192-4d2f-bbbf-fe8637eab146');



DROP TABLE IF EXISTS `craft_taggroups`;


--
-- Schema for table `craft_taggroups`
--
CREATE TABLE `craft_taggroups` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `name` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `handle` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `fieldLayoutId` int(10) DEFAULT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_taggroups_name_unq_idx` (`name`),
  UNIQUE KEY `craft_taggroups_handle_unq_idx` (`handle`),
  KEY `craft_taggroups_fieldLayoutId_fk` (`fieldLayoutId`)
) ENGINE=InnoDB AUTO_INCREMENT=2 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

--
-- Data for table `craft_taggroups`
--

INSERT INTO `craft_taggroups` (`id`, `name`, `handle`, `fieldLayoutId`, `dateCreated`, `dateUpdated`, `uid`) VALUES
 ('1', 'Default', 'default', '1', '2018-01-24 18:37:17', '2018-01-24 18:37:17', '30271b38-2490-4349-82d2-fad27fad9563');



DROP TABLE IF EXISTS `craft_tags`;


--
-- Schema for table `craft_tags`
--
CREATE TABLE `craft_tags` (
  `id` int(11) NOT NULL,
  `groupId` int(11) NOT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  KEY `craft_tags_groupId_fk` (`groupId`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_tasks`;


--
-- Schema for table `craft_tasks`
--
CREATE TABLE `craft_tasks` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `root` int(11) unsigned DEFAULT NULL,
  `lft` int(11) unsigned NOT NULL,
  `rgt` int(11) unsigned NOT NULL,
  `level` smallint(6) unsigned NOT NULL,
  `currentStep` int(11) unsigned DEFAULT NULL,
  `totalSteps` int(11) unsigned DEFAULT NULL,
  `status` enum('pending','error','running') COLLATE utf8_unicode_ci DEFAULT NULL,
  `type` varchar(150) COLLATE utf8_unicode_ci NOT NULL,
  `description` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `settings` mediumtext COLLATE utf8_unicode_ci,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  KEY `craft_tasks_root_idx` (`root`),
  KEY `craft_tasks_lft_idx` (`lft`),
  KEY `craft_tasks_rgt_idx` (`rgt`),
  KEY `craft_tasks_level_idx` (`level`)
) ENGINE=InnoDB AUTO_INCREMENT=15 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_templatecachecriteria`;


--
-- Schema for table `craft_templatecachecriteria`
--
CREATE TABLE `craft_templatecachecriteria` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `cacheId` int(11) NOT NULL,
  `type` varchar(150) COLLATE utf8_unicode_ci NOT NULL,
  `criteria` text COLLATE utf8_unicode_ci NOT NULL,
  PRIMARY KEY (`id`),
  KEY `craft_templatecachecriteria_cacheId_fk` (`cacheId`),
  KEY `craft_templatecachecriteria_type_idx` (`type`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_templatecacheelements`;


--
-- Schema for table `craft_templatecacheelements`
--
CREATE TABLE `craft_templatecacheelements` (
  `cacheId` int(11) NOT NULL,
  `elementId` int(11) NOT NULL,
  KEY `craft_templatecacheelements_cacheId_fk` (`cacheId`),
  KEY `craft_templatecacheelements_elementId_fk` (`elementId`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_templatecaches`;


--
-- Schema for table `craft_templatecaches`
--
CREATE TABLE `craft_templatecaches` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `cacheKey` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `locale` char(12) COLLATE utf8_unicode_ci NOT NULL,
  `path` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `expiryDate` datetime NOT NULL,
  `body` mediumtext COLLATE utf8_unicode_ci NOT NULL,
  PRIMARY KEY (`id`),
  KEY `craft_templatecaches_cacheKey_locale_expiryDate_path_idx` (`cacheKey`,`locale`,`expiryDate`,`path`),
  KEY `craft_templatecaches_cacheKey_locale_expiryDate_idx` (`cacheKey`,`locale`,`expiryDate`),
  KEY `craft_templatecaches_locale_fk` (`locale`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_tokens`;


--
-- Schema for table `craft_tokens`
--
CREATE TABLE `craft_tokens` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `token` char(32) COLLATE utf8_unicode_ci NOT NULL,
  `route` text COLLATE utf8_unicode_ci,
  `usageLimit` tinyint(3) unsigned DEFAULT NULL,
  `usageCount` tinyint(3) unsigned DEFAULT NULL,
  `expiryDate` datetime NOT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_tokens_token_unq_idx` (`token`),
  KEY `craft_tokens_expiryDate_idx` (`expiryDate`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_usergroups`;


--
-- Schema for table `craft_usergroups`
--
CREATE TABLE `craft_usergroups` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `name` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `handle` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_usergroups_name_unq_idx` (`name`),
  UNIQUE KEY `craft_usergroups_handle_unq_idx` (`handle`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_usergroups_users`;


--
-- Schema for table `craft_usergroups_users`
--
CREATE TABLE `craft_usergroups_users` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `groupId` int(11) NOT NULL,
  `userId` int(11) NOT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_usergroups_users_groupId_userId_unq_idx` (`groupId`,`userId`),
  KEY `craft_usergroups_users_userId_fk` (`userId`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_userpermissions`;


--
-- Schema for table `craft_userpermissions`
--
CREATE TABLE `craft_userpermissions` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `name` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_userpermissions_name_unq_idx` (`name`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_userpermissions_usergroups`;


--
-- Schema for table `craft_userpermissions_usergroups`
--
CREATE TABLE `craft_userpermissions_usergroups` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `permissionId` int(11) NOT NULL,
  `groupId` int(11) NOT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_userpermissions_usergroups_permissionId_groupId_unq_idx` (`permissionId`,`groupId`),
  KEY `craft_userpermissions_usergroups_groupId_fk` (`groupId`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_userpermissions_users`;


--
-- Schema for table `craft_userpermissions_users`
--
CREATE TABLE `craft_userpermissions_users` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `permissionId` int(11) NOT NULL,
  `userId` int(11) NOT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_userpermissions_users_permissionId_userId_unq_idx` (`permissionId`,`userId`),
  KEY `craft_userpermissions_users_userId_fk` (`userId`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

DROP TABLE IF EXISTS `craft_users`;


--
-- Schema for table `craft_users`
--
CREATE TABLE `craft_users` (
  `id` int(11) NOT NULL,
  `username` varchar(100) COLLATE utf8_unicode_ci NOT NULL,
  `photo` varchar(100) COLLATE utf8_unicode_ci DEFAULT NULL,
  `firstName` varchar(100) COLLATE utf8_unicode_ci DEFAULT NULL,
  `lastName` varchar(100) COLLATE utf8_unicode_ci DEFAULT NULL,
  `email` varchar(255) COLLATE utf8_unicode_ci NOT NULL,
  `password` char(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `preferredLocale` char(12) COLLATE utf8_unicode_ci DEFAULT NULL,
  `weekStartDay` tinyint(1) unsigned NOT NULL DEFAULT '0',
  `admin` tinyint(1) unsigned NOT NULL DEFAULT '0',
  `client` tinyint(1) unsigned NOT NULL DEFAULT '0',
  `locked` tinyint(1) unsigned NOT NULL DEFAULT '0',
  `suspended` tinyint(1) unsigned NOT NULL DEFAULT '0',
  `pending` tinyint(1) unsigned NOT NULL DEFAULT '0',
  `archived` tinyint(1) unsigned NOT NULL DEFAULT '0',
  `lastLoginDate` datetime DEFAULT NULL,
  `lastLoginAttemptIPAddress` varchar(45) COLLATE utf8_unicode_ci DEFAULT NULL,
  `invalidLoginWindowStart` datetime DEFAULT NULL,
  `invalidLoginCount` tinyint(4) unsigned DEFAULT NULL,
  `lastInvalidLoginDate` datetime DEFAULT NULL,
  `lockoutDate` datetime DEFAULT NULL,
  `verificationCode` char(100) COLLATE utf8_unicode_ci DEFAULT NULL,
  `verificationCodeIssuedDate` datetime DEFAULT NULL,
  `unverifiedEmail` varchar(255) COLLATE utf8_unicode_ci DEFAULT NULL,
  `passwordResetRequired` tinyint(1) unsigned NOT NULL DEFAULT '0',
  `lastPasswordChangeDate` datetime DEFAULT NULL,
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  UNIQUE KEY `craft_users_username_unq_idx` (`username`),
  UNIQUE KEY `craft_users_email_unq_idx` (`email`),
  KEY `craft_users_verificationCode_idx` (`verificationCode`),
  KEY `craft_users_uid_idx` (`uid`),
  KEY `craft_users_preferredLocale_fk` (`preferredLocale`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

--
-- Data for table `craft_users`
--

INSERT INTO `craft_users` (`id`, `username`, `photo`, `firstName`, `lastName`, `email`, `password`, `preferredLocale`, `weekStartDay`, `admin`, `client`, `locked`, `suspended`, `pending`, `archived`, `lastLoginDate`, `lastLoginAttemptIPAddress`, `invalidLoginWindowStart`, `invalidLoginCount`, `lastInvalidLoginDate`, `lockoutDate`, `verificationCode`, `verificationCodeIssuedDate`, `unverifiedEmail`, `passwordResetRequired`, `lastPasswordChangeDate`, `dateCreated`, `dateUpdated`, `uid`) VALUES
 ('1', 'jasonroot', NULL, '', '', 'hello@jasonroot.com', '$2y$13$BAX8pdSvGUyY39qZb7jtVOKb8r7xccajoKAabkXPalRAws0kJFyhe', NULL, '0', '1', '0', '0', '0', '0', '0', '2018-02-09 18:50:51', '72.175.104.194', NULL, NULL, NULL, NULL, NULL, NULL, NULL, '0', '2018-02-03 17:48:05', '2018-01-24 18:37:16', '2018-02-09 18:50:51', '7063b458-2245-4d6d-bb4b-590b4082889f');



DROP TABLE IF EXISTS `craft_widgets`;


--
-- Schema for table `craft_widgets`
--
CREATE TABLE `craft_widgets` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `userId` int(11) NOT NULL,
  `type` varchar(150) COLLATE utf8_unicode_ci NOT NULL,
  `sortOrder` smallint(6) unsigned DEFAULT NULL,
  `colspan` tinyint(4) unsigned DEFAULT NULL,
  `settings` text COLLATE utf8_unicode_ci,
  `enabled` tinyint(1) unsigned NOT NULL DEFAULT '1',
  `dateCreated` datetime NOT NULL,
  `dateUpdated` datetime NOT NULL,
  `uid` char(36) COLLATE utf8_unicode_ci NOT NULL DEFAULT '0',
  PRIMARY KEY (`id`),
  KEY `craft_widgets_userId_fk` (`userId`)
) ENGINE=InnoDB AUTO_INCREMENT=5 DEFAULT CHARSET=utf8 COLLATE=utf8_unicode_ci;

--
-- Data for table `craft_widgets`
--

INSERT INTO `craft_widgets` (`id`, `userId`, `type`, `sortOrder`, `colspan`, `settings`, `enabled`, `dateCreated`, `dateUpdated`, `uid`) VALUES
 ('1', '1', 'RecentEntries', '1', NULL, NULL, '1', '2018-01-24 18:37:20', '2018-01-24 18:37:20', '491aa128-381e-4b1e-8ca2-aed34e13cb00'),
 ('2', '1', 'GetHelp', '2', NULL, NULL, '1', '2018-01-24 18:37:20', '2018-01-24 18:37:20', '6d7624e9-6378-4173-b774-a09262d78e53'),
 ('3', '1', 'Updates', '3', NULL, NULL, '1', '2018-01-24 18:37:20', '2018-01-24 18:37:20', '6a1c0548-9fc8-4f89-9bc8-d533a4d9e666'),
 ('4', '1', 'Feed', '4', NULL, '{\"url\":\"https:\\/\\/craftcms.com\\/news.rss\",\"title\":\"Craft News\"}', '1', '2018-01-24 18:37:20', '2018-01-24 18:37:20', 'cf70cdd1-43bc-48ed-907e-9e511bd2f2bb');


--
-- Constraints for tables
--


--
-- Constraints for table `craft_assetfiles`
--
ALTER TABLE `craft_assetfiles`
	ADD CONSTRAINT `craft_assetfiles_folderId_fk` FOREIGN KEY (`folderId`) REFERENCES `craft_assetfolders` (`id`) ON DELETE CASCADE,
	ADD CONSTRAINT `craft_assetfiles_id_fk` FOREIGN KEY (`id`) REFERENCES `craft_elements` (`id`) ON DELETE CASCADE,
	ADD CONSTRAINT `craft_assetfiles_sourceId_fk` FOREIGN KEY (`sourceId`) REFERENCES `craft_assetsources` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_assetfolders`
--
ALTER TABLE `craft_assetfolders`
	ADD CONSTRAINT `craft_assetfolders_sourceId_fk` FOREIGN KEY (`sourceId`) REFERENCES `craft_assetsources` (`id`) ON DELETE CASCADE,
	ADD CONSTRAINT `craft_assetfolders_parentId_fk` FOREIGN KEY (`parentId`) REFERENCES `craft_assetfolders` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_assetindexdata`
--
ALTER TABLE `craft_assetindexdata`
	ADD CONSTRAINT `craft_assetindexdata_sourceId_fk` FOREIGN KEY (`sourceId`) REFERENCES `craft_assetsources` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_assetsources`
--
ALTER TABLE `craft_assetsources`
	ADD CONSTRAINT `craft_assetsources_fieldLayoutId_fk` FOREIGN KEY (`fieldLayoutId`) REFERENCES `craft_fieldlayouts` (`id`) ON DELETE SET NULL;

--
-- Constraints for table `craft_categories`
--
ALTER TABLE `craft_categories`
	ADD CONSTRAINT `craft_categories_groupId_fk` FOREIGN KEY (`groupId`) REFERENCES `craft_categorygroups` (`id`) ON DELETE CASCADE,
	ADD CONSTRAINT `craft_categories_id_fk` FOREIGN KEY (`id`) REFERENCES `craft_elements` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_categorygroups`
--
ALTER TABLE `craft_categorygroups`
	ADD CONSTRAINT `craft_categorygroups_fieldLayoutId_fk` FOREIGN KEY (`fieldLayoutId`) REFERENCES `craft_fieldlayouts` (`id`) ON DELETE SET NULL,
	ADD CONSTRAINT `craft_categorygroups_structureId_fk` FOREIGN KEY (`structureId`) REFERENCES `craft_structures` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_categorygroups_i18n`
--
ALTER TABLE `craft_categorygroups_i18n`
	ADD CONSTRAINT `craft_categorygroups_i18n_locale_fk` FOREIGN KEY (`locale`) REFERENCES `craft_locales` (`locale`) ON DELETE CASCADE ON UPDATE CASCADE,
	ADD CONSTRAINT `craft_categorygroups_i18n_groupId_fk` FOREIGN KEY (`groupId`) REFERENCES `craft_categorygroups` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_content`
--
ALTER TABLE `craft_content`
	ADD CONSTRAINT `craft_content_elementId_fk` FOREIGN KEY (`elementId`) REFERENCES `craft_elements` (`id`) ON DELETE CASCADE,
	ADD CONSTRAINT `craft_content_locale_fk` FOREIGN KEY (`locale`) REFERENCES `craft_locales` (`locale`) ON DELETE CASCADE ON UPDATE CASCADE;

--
-- Constraints for table `craft_elements_i18n`
--
ALTER TABLE `craft_elements_i18n`
	ADD CONSTRAINT `craft_elements_i18n_locale_fk` FOREIGN KEY (`locale`) REFERENCES `craft_locales` (`locale`) ON DELETE CASCADE ON UPDATE CASCADE,
	ADD CONSTRAINT `craft_elements_i18n_elementId_fk` FOREIGN KEY (`elementId`) REFERENCES `craft_elements` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_emailmessages`
--
ALTER TABLE `craft_emailmessages`
	ADD CONSTRAINT `craft_emailmessages_locale_fk` FOREIGN KEY (`locale`) REFERENCES `craft_locales` (`locale`) ON DELETE CASCADE ON UPDATE CASCADE;

--
-- Constraints for table `craft_entries`
--
ALTER TABLE `craft_entries`
	ADD CONSTRAINT `craft_entries_authorId_fk` FOREIGN KEY (`authorId`) REFERENCES `craft_users` (`id`) ON DELETE CASCADE,
	ADD CONSTRAINT `craft_entries_id_fk` FOREIGN KEY (`id`) REFERENCES `craft_elements` (`id`) ON DELETE CASCADE,
	ADD CONSTRAINT `craft_entries_sectionId_fk` FOREIGN KEY (`sectionId`) REFERENCES `craft_sections` (`id`) ON DELETE CASCADE,
	ADD CONSTRAINT `craft_entries_typeId_fk` FOREIGN KEY (`typeId`) REFERENCES `craft_entrytypes` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_entrydrafts`
--
ALTER TABLE `craft_entrydrafts`
	ADD CONSTRAINT `craft_entrydrafts_locale_fk` FOREIGN KEY (`locale`) REFERENCES `craft_locales` (`locale`) ON DELETE CASCADE ON UPDATE CASCADE,
	ADD CONSTRAINT `craft_entrydrafts_creatorId_fk` FOREIGN KEY (`creatorId`) REFERENCES `craft_users` (`id`) ON DELETE CASCADE,
	ADD CONSTRAINT `craft_entrydrafts_entryId_fk` FOREIGN KEY (`entryId`) REFERENCES `craft_entries` (`id`) ON DELETE CASCADE,
	ADD CONSTRAINT `craft_entrydrafts_sectionId_fk` FOREIGN KEY (`sectionId`) REFERENCES `craft_sections` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_entrytypes`
--
ALTER TABLE `craft_entrytypes`
	ADD CONSTRAINT `craft_entrytypes_fieldLayoutId_fk` FOREIGN KEY (`fieldLayoutId`) REFERENCES `craft_fieldlayouts` (`id`) ON DELETE SET NULL,
	ADD CONSTRAINT `craft_entrytypes_sectionId_fk` FOREIGN KEY (`sectionId`) REFERENCES `craft_sections` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_entryversions`
--
ALTER TABLE `craft_entryversions`
	ADD CONSTRAINT `craft_entryversions_locale_fk` FOREIGN KEY (`locale`) REFERENCES `craft_locales` (`locale`) ON DELETE CASCADE ON UPDATE CASCADE,
	ADD CONSTRAINT `craft_entryversions_creatorId_fk` FOREIGN KEY (`creatorId`) REFERENCES `craft_users` (`id`) ON DELETE SET NULL,
	ADD CONSTRAINT `craft_entryversions_entryId_fk` FOREIGN KEY (`entryId`) REFERENCES `craft_entries` (`id`) ON DELETE CASCADE,
	ADD CONSTRAINT `craft_entryversions_sectionId_fk` FOREIGN KEY (`sectionId`) REFERENCES `craft_sections` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_fieldlayoutfields`
--
ALTER TABLE `craft_fieldlayoutfields`
	ADD CONSTRAINT `craft_fieldlayoutfields_fieldId_fk` FOREIGN KEY (`fieldId`) REFERENCES `craft_fields` (`id`) ON DELETE CASCADE,
	ADD CONSTRAINT `craft_fieldlayoutfields_layoutId_fk` FOREIGN KEY (`layoutId`) REFERENCES `craft_fieldlayouts` (`id`) ON DELETE CASCADE,
	ADD CONSTRAINT `craft_fieldlayoutfields_tabId_fk` FOREIGN KEY (`tabId`) REFERENCES `craft_fieldlayouttabs` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_fieldlayouttabs`
--
ALTER TABLE `craft_fieldlayouttabs`
	ADD CONSTRAINT `craft_fieldlayouttabs_layoutId_fk` FOREIGN KEY (`layoutId`) REFERENCES `craft_fieldlayouts` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_fields`
--
ALTER TABLE `craft_fields`
	ADD CONSTRAINT `craft_fields_groupId_fk` FOREIGN KEY (`groupId`) REFERENCES `craft_fieldgroups` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_globalsets`
--
ALTER TABLE `craft_globalsets`
	ADD CONSTRAINT `craft_globalsets_fieldLayoutId_fk` FOREIGN KEY (`fieldLayoutId`) REFERENCES `craft_fieldlayouts` (`id`) ON DELETE SET NULL,
	ADD CONSTRAINT `craft_globalsets_id_fk` FOREIGN KEY (`id`) REFERENCES `craft_elements` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_matrixblocks`
--
ALTER TABLE `craft_matrixblocks`
	ADD CONSTRAINT `craft_matrixblocks_typeId_fk` FOREIGN KEY (`typeId`) REFERENCES `craft_matrixblocktypes` (`id`) ON DELETE CASCADE,
	ADD CONSTRAINT `craft_matrixblocks_fieldId_fk` FOREIGN KEY (`fieldId`) REFERENCES `craft_fields` (`id`) ON DELETE CASCADE,
	ADD CONSTRAINT `craft_matrixblocks_id_fk` FOREIGN KEY (`id`) REFERENCES `craft_elements` (`id`) ON DELETE CASCADE,
	ADD CONSTRAINT `craft_matrixblocks_ownerId_fk` FOREIGN KEY (`ownerId`) REFERENCES `craft_elements` (`id`) ON DELETE CASCADE,
	ADD CONSTRAINT `craft_matrixblocks_ownerLocale_fk` FOREIGN KEY (`ownerLocale`) REFERENCES `craft_locales` (`locale`) ON DELETE CASCADE ON UPDATE CASCADE;

--
-- Constraints for table `craft_matrixblocktypes`
--
ALTER TABLE `craft_matrixblocktypes`
	ADD CONSTRAINT `craft_matrixblocktypes_fieldLayoutId_fk` FOREIGN KEY (`fieldLayoutId`) REFERENCES `craft_fieldlayouts` (`id`) ON DELETE SET NULL,
	ADD CONSTRAINT `craft_matrixblocktypes_fieldId_fk` FOREIGN KEY (`fieldId`) REFERENCES `craft_fields` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_migrations`
--
ALTER TABLE `craft_migrations`
	ADD CONSTRAINT `craft_migrations_pluginId_fk` FOREIGN KEY (`pluginId`) REFERENCES `craft_plugins` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_relations`
--
ALTER TABLE `craft_relations`
	ADD CONSTRAINT `craft_relations_targetId_fk` FOREIGN KEY (`targetId`) REFERENCES `craft_elements` (`id`) ON DELETE CASCADE,
	ADD CONSTRAINT `craft_relations_fieldId_fk` FOREIGN KEY (`fieldId`) REFERENCES `craft_fields` (`id`) ON DELETE CASCADE,
	ADD CONSTRAINT `craft_relations_sourceId_fk` FOREIGN KEY (`sourceId`) REFERENCES `craft_elements` (`id`) ON DELETE CASCADE,
	ADD CONSTRAINT `craft_relations_sourceLocale_fk` FOREIGN KEY (`sourceLocale`) REFERENCES `craft_locales` (`locale`) ON DELETE CASCADE ON UPDATE CASCADE;

--
-- Constraints for table `craft_routes`
--
ALTER TABLE `craft_routes`
	ADD CONSTRAINT `craft_routes_locale_fk` FOREIGN KEY (`locale`) REFERENCES `craft_locales` (`locale`) ON DELETE CASCADE ON UPDATE CASCADE;

--
-- Constraints for table `craft_sections`
--
ALTER TABLE `craft_sections`
	ADD CONSTRAINT `craft_sections_structureId_fk` FOREIGN KEY (`structureId`) REFERENCES `craft_structures` (`id`) ON DELETE SET NULL;

--
-- Constraints for table `craft_sections_i18n`
--
ALTER TABLE `craft_sections_i18n`
	ADD CONSTRAINT `craft_sections_i18n_locale_fk` FOREIGN KEY (`locale`) REFERENCES `craft_locales` (`locale`) ON DELETE CASCADE ON UPDATE CASCADE,
	ADD CONSTRAINT `craft_sections_i18n_sectionId_fk` FOREIGN KEY (`sectionId`) REFERENCES `craft_sections` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_sessions`
--
ALTER TABLE `craft_sessions`
	ADD CONSTRAINT `craft_sessions_userId_fk` FOREIGN KEY (`userId`) REFERENCES `craft_users` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_shunnedmessages`
--
ALTER TABLE `craft_shunnedmessages`
	ADD CONSTRAINT `craft_shunnedmessages_userId_fk` FOREIGN KEY (`userId`) REFERENCES `craft_users` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_structureelements`
--
ALTER TABLE `craft_structureelements`
	ADD CONSTRAINT `craft_structureelements_elementId_fk` FOREIGN KEY (`elementId`) REFERENCES `craft_elements` (`id`) ON DELETE CASCADE,
	ADD CONSTRAINT `craft_structureelements_structureId_fk` FOREIGN KEY (`structureId`) REFERENCES `craft_structures` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_taggroups`
--
ALTER TABLE `craft_taggroups`
	ADD CONSTRAINT `craft_taggroups_fieldLayoutId_fk` FOREIGN KEY (`fieldLayoutId`) REFERENCES `craft_fieldlayouts` (`id`) ON DELETE SET NULL;

--
-- Constraints for table `craft_tags`
--
ALTER TABLE `craft_tags`
	ADD CONSTRAINT `craft_tags_groupId_fk` FOREIGN KEY (`groupId`) REFERENCES `craft_taggroups` (`id`) ON DELETE CASCADE,
	ADD CONSTRAINT `craft_tags_id_fk` FOREIGN KEY (`id`) REFERENCES `craft_elements` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_templatecachecriteria`
--
ALTER TABLE `craft_templatecachecriteria`
	ADD CONSTRAINT `craft_templatecachecriteria_cacheId_fk` FOREIGN KEY (`cacheId`) REFERENCES `craft_templatecaches` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_templatecacheelements`
--
ALTER TABLE `craft_templatecacheelements`
	ADD CONSTRAINT `craft_templatecacheelements_elementId_fk` FOREIGN KEY (`elementId`) REFERENCES `craft_elements` (`id`) ON DELETE CASCADE,
	ADD CONSTRAINT `craft_templatecacheelements_cacheId_fk` FOREIGN KEY (`cacheId`) REFERENCES `craft_templatecaches` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_templatecaches`
--
ALTER TABLE `craft_templatecaches`
	ADD CONSTRAINT `craft_templatecaches_locale_fk` FOREIGN KEY (`locale`) REFERENCES `craft_locales` (`locale`) ON DELETE CASCADE ON UPDATE CASCADE;

--
-- Constraints for table `craft_usergroups_users`
--
ALTER TABLE `craft_usergroups_users`
	ADD CONSTRAINT `craft_usergroups_users_userId_fk` FOREIGN KEY (`userId`) REFERENCES `craft_users` (`id`) ON DELETE CASCADE,
	ADD CONSTRAINT `craft_usergroups_users_groupId_fk` FOREIGN KEY (`groupId`) REFERENCES `craft_usergroups` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_userpermissions_usergroups`
--
ALTER TABLE `craft_userpermissions_usergroups`
	ADD CONSTRAINT `craft_userpermissions_usergroups_groupId_fk` FOREIGN KEY (`groupId`) REFERENCES `craft_usergroups` (`id`) ON DELETE CASCADE,
	ADD CONSTRAINT `craft_userpermissions_usergroups_permissionId_fk` FOREIGN KEY (`permissionId`) REFERENCES `craft_userpermissions` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_userpermissions_users`
--
ALTER TABLE `craft_userpermissions_users`
	ADD CONSTRAINT `craft_userpermissions_users_userId_fk` FOREIGN KEY (`userId`) REFERENCES `craft_users` (`id`) ON DELETE CASCADE,
	ADD CONSTRAINT `craft_userpermissions_users_permissionId_fk` FOREIGN KEY (`permissionId`) REFERENCES `craft_userpermissions` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_users`
--
ALTER TABLE `craft_users`
	ADD CONSTRAINT `craft_users_preferredLocale_fk` FOREIGN KEY (`preferredLocale`) REFERENCES `craft_locales` (`locale`) ON DELETE SET NULL ON UPDATE CASCADE,
	ADD CONSTRAINT `craft_users_id_fk` FOREIGN KEY (`id`) REFERENCES `craft_elements` (`id`) ON DELETE CASCADE;

--
-- Constraints for table `craft_widgets`
--
ALTER TABLE `craft_widgets`
	ADD CONSTRAINT `craft_widgets_userId_fk` FOREIGN KEY (`userId`) REFERENCES `craft_users` (`id`) ON DELETE CASCADE;

SET FOREIGN_KEY_CHECKS = 1;
